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Prostate cancer is the most common non-skin cancer i  United States men.  
Despite recent advances, mortality still remains high due to the emergence of therapy-
resistant cancer cells that metastasize.  Recently it has been postulated that only cancer 
stem cells (CSCs) are able to establish metastases, nd therefore are the essential targets 
to destroy.  Unfortunately, current use of CSCs is limited by the small number of CSCs 
that can be isolated, and the difficulty of culturing the CSCs in vitro.  Furthermore, 
current in vitro-based metastatic prostate cancer models do not faithfully recreate the 
complex multi-cellular, three-dimensional (3D) tumor microenvironment seen i vivo.  It 
is therefore crucial to develop effective in vitro prostate cancer culture and testing 
systems that mimic the actual in vivo tumor niche microenvironment.  Here we utilized 
novel microscale technologies to develop an accurate 3D metastatic tumor model for 
detailed study of metastatic prostate cancer dormancy s well as accurate anti-cancer 
therapeutics screening and testing in vitro.  Guided by the observation that prostate 
cancer cells parasitize and stay quiescent in the hematopoietic stem cell niche that is rich 
in osteoblasts and endothelial cells in vivo, a microfluidic device was established to create 
3D spheroid culture of prostate cancer cells supported by osteoblasts and endothelial cells.  
This 3D metastatic prostate cancer model recapitulates the physiologic, dormant growth 
behavior of prostate cancer cells in the hematopoietic stem cell niche.  Furthermore, we 
developed a hanging drop-based high-throughput platform for general formation, stable 
 xvi 
long-term culture, and robust drug testing and screening of 3D spheroids.  Using this 
platform, we found significant differences in drug sensitivities against cells cultured 
under conventional 2D conditions versus physiological 3D models.  A variety of 
techniques and methods were also established to specifically pattern the spatial 
localization of different co-culture cell types within a spheroid in this platform for 
accurate engineering of the 3D metastatic prostate c ncer niche microenvironment.  
Collectively, these biological findings and technological innovations have led to 
advances in the understanding of prostate cancer biology and progress towards 






Cancer is the second leading cause of death in the Unit d States (Comprehensive 
Cancer Information—National Cancer Institute).  Developments in the past decades have 
no doubt brought significant advancements to our cur ent understanding and treatments 
of cancer.  Nevertheless, as of today, many metastatic cancers such as prostate cancer still 
remain incurable.  Prostate cancer is the most common non-skin cancer in United States 
men (Prostate Cancer Foundation).  Despite recent advances, prostate cancer mortality 
still remains high due to the emergence of therapy-resistant cancer cells that metastasize 
(Hellerstedt and Pienta 2002).  It has been postulated that only a subset of cancer cells 
called cancer stem cells (CSCs) are able to establih metastases and regenerate tumors (Li 
et al. 2007; Croker and Allan 2008; Kelly and Yin 2008).  In turn, these CSCs directly 
contribute to the progression of prostate cancer metastasis and ultimately lead to deaths in 
patients.  Therefore, it is critical to find novel approaches to specifically target and 
destroy prostate CSCs.  An understanding of these prostate CSCs has fundamental 
impacts in cancer biology and advancements in medicine. 
 
Unfortunately, current use of CSCs is limited by the small number of CSCs that 
can be isolated and the difficulty of maintaining the CSCs in undifferentiated states in in 
vitro cultures.  CSCs typically only make up 0.1 to 2% of the bulk cancer cell population.  
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Culture of isolated CSCs in the conventional two-dimensional (2D) petri-dishes generally 
leads to spontaneous differentiation back to the bulk cancer cell population.  
Alternatively, CSCs have been enriched in animal models (Al-Hajj et al. 2003), but such 
in vivo cultures are very tedious, expensive, and not effici nt.  It is therefore essential to 
develop an effective in vitro CSC culture and testing system to better study the biology of 
these delicate CSCs.  Just like how normal stem cells tend to reside in special “niches,” it 
has also been suggested that CSCs are likely to be maintained in microenvironmental 
niches in tumors (Dontu et al. 2005; Croker and Allan 2008; Kelly and Yin 2008; Li and 
Neaves 2006; Li et al. 2007).  However, current in vitro-based metastatic prostate cancer 
models do not faithfully recreate the complex multi-cellular, three-dimensional (3D) 
tumor microenvironments seen i  vivo.  Taking into account the importance of stem cell-
niche interactions, it is crucial to develop a system that mimics the actual in vivo CSC 
niche microenvironment in vitro. 
 
The work described in this dissertation presents multidisciplinary efforts directed 
towards the development of novel microscale systems to engineer accurate 3D metastatic 
prostate cancer and CSC models in vitro for detailed study of dormancy and anti-cancer 
drug development.  The central biological concept of the thesis is built upon the niche 
parasitism hypothesis (proposed by Professor Russell S. Taichman and Professor 
Kenneth J. Pienta at the University of Michigan’s Dental School and Medical School), 
which states that prostate cancer metastasis to the bon  is mediated by prostate CSCs that 
localize to the hematopoietic stem cell (HSC) niche and function as parasites on the niche 
to facilitate growth and survival (Shiozawa et al. 2008; Shiozawa et al. 2008; Shiozawa 
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et al. 2010).  The HSC niche, in turn, is comprised of multiple cell types including 
osteoblasts and endothelial cells delicately organized into 3D structures with tightly 
regulated oxygen tension (Shiozawa et al. 2008; Yin and Li 2006).  Replication of such 
complex in vivo niche organization in vitro requires highly sophisticated 3D cell co-
culture systems to be engineered to capture all the vital elements of the niche.  This 
research effort has utilized novel microscale technologies to create 3D in vitro niches to 
mimic the prostate CSC and bulk prostate cancer cell microenvironment at the bone 
metastatic site.  Such metastatic prostate cancer model can subsequently be used to study 
tumor dormancy and serve as base model for anti-cancer drug screening and testing. 
 
To mimic in vivo situations in vitro accurately, the concepts of 3D culture and co-
culture of multiple cell types become highly essential.  With the realization that the 
surrounding environment is critical to cells, various 3D culture systems that better mimic 
physiological tissues have been valued as important esearch tools.  Spheroids, which are 
spherical clusters of cells formed by self-assembly, stand out as one of the best models 
for 3D culture (Kunz-Schughart e al. 2004; Friedrich et al. 2009).  Due to their spherical 
structure, spheroids are excellent models for solid tumors and are known to provide more 
accurate and meaningful biological readouts compared to 2D models (Kunz-Schughart et 
al. 2004).  Multiple cell types can also be incorporated into a single spheroid construct as 
co-culture model (Kelm and Fussenegger 2004).  Currently, however, most biological 
experiments and studies in drug development are still based on 2D cell assays, which 
often skew research results and have limited predictive power in clinical efficacy 
(Hirschhaeuser et al. 2010).  Although the advantages of 3D spheroid cultures are widely 
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known, typical spheroid culture methods are often tdious, low-throughput, difficult to 
handle, and produce non-uniform samples.  Various sch complications have thus 
hindered more researchers from adapting the more accur te 3D spheroid cultures into 
routine use in research. 
 
Recent advances in micro-technologies offer great potentials to improve current 
state of the art in vitro-based cell culture systems for accurate biological studies.  
Microfluidic systems allow for integration of physiologically relevant elements and 
dimensions into in vitro cell culture devices in a simplified and efficient manner without 
extra operational complexities.  Custom engineered platforms also allow for creation of 
multiple independent cellular compartments in high-throughput manners for parallel 
experiments, multiplexing, screening, and testing purposes. 
 
The objective of this thesis research was to develop 3D cell culture platforms 
specifically designed to advance the understanding of prostate cancer metastasis and 
enhance current 3D anti-cancer drug screening and testing standards.  The common 
themes among the research presented in this thesis include microscale systems and 3D 
spheroid cultures.  Specifically, Chapter 2 describes the establishment and 
characterization of an accurate in vitro 3D metastatic prostate cancer model containing 
bulk prostate cancer cells and potential prostate CSCs.  Guided by the recent observation 
that prostate CSCs parasitize to the HSC niche that is rich in osteoblasts and endothelial 
cells in vivo, a microfluidic device was used to create 3D spheroid culture of prostate 
cancer cells and prostate CSC-enriched CD133+ subpopulation supported by osteoblasts 
 
 5 
and endothelial cells.  The growth behavior of the prostate cancer cells and CD133+ 
prostate cancer cells in this model was subsequently characterized and found to be 
relatively quiescent.  This model recapitulates the p ysiologic, quiescent growth behavior 
of prostate cancer cells and CD133+ subpopulation in the HSC niche at their dormancy 
stage of metastasis, which is an excellent intervention point to prevent the outbreak of a 
full-blown metastasis that is often lethal.  Since th  dormant growth phenomenon of 
prostate cancer cells and CD133+ prostate cancer cells in the model closely mimics the 
behavior of prostate cancer cells in vivo when they parasitize the HSC niche, the model is 
excellent for detailed biological studies of dormancy in prostate cancer metastasis and 
development of therapeutics that specifically target dormant metastatic prostate cancer 
cells.  The quiescent behavior of the cells is an important characteristic of tumor 
dormancy that had not been previously achieved in conventional 2D mono-cultures.  It is 
a feature of cancer metastasis previously difficult to study and recapitulate in vitro. 
 
The work from Chapter 3 also extends the theme of microscale 3D spheroid 
culture, but here the system is scaled up to a high-throughput platform that can easily be 
mass produced for high-throughput screening (HTS) purposes.  This new innovation 
greatly simplifies the tedious procedures required by the conventional spheroid formation 
methods and makes 3D cell culture as straightforward as conventional 2D cultures.  The 
platform is based on the conventional spheroid formation method—hanging drop 
technique, and is designed to the standard 384-well plate format for compatibility with 
existing HTS instruments.  This versatile 384 hanging drop array plate is not just for the 
culture of the metastatic prostate cancer models, but could also be used for 3D spheroid 
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formation of a wide variety of normal and diseased c ll types.  Using this platform, two 
distinct anti-cancer drugs have been demonstrated to have differential effects on cells 
cultured in 2D versus 3D, depending on the drug mode of action.  This system introduces 
a simple, user-friendly solution to the typically complicated, cumbersome, and expensive 
3D cell culture for the entire cell culture community.  The plate is simple enough for 
routine long-term 3D cell culture in academia, yet also in a high-throughput format 
suitable for the pharmaceutical industry.  This platform is envisioned to revolutionize 
current drug screening standards by the introduction of an efficient 3D cell culture based 
HTS platform.  3D cell cultures offer biologically relevant insights that are often lost and 
unattainable from 2D monolayer cultures.  These advantages will positively contribute to 
future advancements in anti-cancer therapeutics. 
 
Building upon the development described in Chapter 3, Chapter 4 further 
characterizes and improves the 384 hanging drop array plate to promote wider use of the 
high-throughput platform by a broader range of disciplines.  The plate is shown to have 
excellent assay performances and therefore demonstrate  its suitability for HTS 
applications such as drug screening and testing.  The actual design of the plate was 
further refined to optimize for greater long-term stability of the hanging drops.  The 
versatility of the plate is also demonstrated through the 3D spheroid culture of a wide 
variety of cell types, the ease of spheroid transferring and retrieval for further 
experimentation or analysis, and various 3D co-culture and patterning techniques allowed 




Finally, works from Chapter 5 attempts to elucidate th  factors contributing to the 
quiescent behavior of prostate cancer cells and CD133+ subpopulation observed in the 
metastatic prostate cancer spheroid model described in Chapter 2 by utilizing the high-
throughput 384 hanging drop array platform developed in Chapter 3 and Chapter 4.  
Effort to explore the underlying mechanisms that are regulating the CD133+ prostate 
cancer cells in more depth was achieved through looking at the CD133+ subpopulation’s 
expression levels of key genes implicated in stem cll self-renewal, quiescence, homing, 
and localization.  In addition to the proliferation rate data presented in Chapter 2, the 
quiescence of the prostate cancer cells cultured in the co-culture spheroids was further 
evaluated by looking at their cell cycling stage.  Chapter 5 presents preliminary data on 
current characterizations in the key stem cell-relevant gene expression profiles in the 
CD133+ subpopulation and the cell cycling stage of prostate cancer cells.  Additional 
efforts are required to elucidate the underlying biology in keeping the CD133+ prostate 
cancer cells quiescent and thus maintaining their st m-like markers. 
 
Collectively, this dissertation highlights sophisticated utilization of micro-
technologies to develop user-friendly platforms ande gineer accurate models that closely 
mimic in vivo situations to study and answer fundamental cancer biology questions.  In 
addition, the developed platforms allow for accurate, efficient, and effective drug 
screening and testing on 3D cellular models, which will eventually lead to advancements 
in medicine and anti-cancer therapeutics.  The eventual translational goal is to introduce 
our simple 3D culture technologies to clinicians to enable efficient and reliable formation 
of physiologic tumor microtissues from the small number of patient-specific cancer cells 
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for individualized evaluation of anti-cancer drug sen itivity and develop specialized 
treatment options.  The works described here demonstrate successful development of 
novel cutting-edge devices to improve current research methods in biology by 
establishing physiologically relevant models and introducing user-friendly techniques to 
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Microfluidic System for Formation of PC-3 Prostate Cancer Co-culture 
Spheroids 
 
The niche microenvironment in which cancer cells resid  plays a prominent role 
in the growth of cancer.  It is therefore imperative to mimic the in vivo tumor niche in 
vitro to better understand cancer and enhance development of therapeutics.  Here, we 
engineer a 3D metastatic prostate cancer model that includes the types of surrounding 
cells in the bone microenvironment that the metastaic prostate cancer cells reside in.  
Specifically, we used a two-layer microfluidic system to culture 3D multi-cell type 
spheroids of fluorescently labeled metastatic prostate cancer cells (PC-3 cell line), 
osteoblasts and endothelial cells.  This method ensur s uniform incorporation of all co-
culture cell types into each spheroid and keeps the sp roids stationary for easy tracking 
of individual spheroids and the PC-3’s residing inside them over the course of at least a 
week.  This culture system greatly decreased the proliferation rate of PC-3 cells without 
reducing viability and may more faithfully recapitulate the in vivo growth behavior of 





Cancer stem cells (CSCs) are postulated to be central to the establishment of 
metastases and the main challenge to the cure of cancer (Li et al. 2007; Croker and Allan 
2008; Kelly and Yin 2008).  Currently, however, the use of CSCs in research is limited 
by the small number of CSCs that can be isolated, an  the spontaneous differentiation in 
in vitro cultures.  The challenge of in vitro CSC culture is likely due, at least in part, to 
the lack of supportive microenvironmental niches (Li et al. 2007; Croker and Allan 2008; 
Kelly and Yin 2008; Dontu et al. 2005; Li and Neaves 2006) in conventional two-
dimensional (2D) cultures.  Bone metastasis, which is t e most severe complication and 
leading cause of morbidity and ultimately mortality in prostate cancer (Taichman et al. 
2007; Sun et al. 2007), provides clues for recreating a supportive CSC niche environment 
for prostate cancer cells.  Recent data from our group suggests that prostate cancer 
utilizes the hematopoietic stem cell (HSC) homing mechanisms to metastasize to the 
bone marrow and thrive in the niche (Shiozawa et al. 2008; 2010).  Based on this 
hypothesis that prostate cancers parasitize the niche, we have developed microscale 3D 
spheroid culture of prostate cancer cells supported by cells from the HSC niche.  Here, 
we describe a microfluidic 3D culture system that recapitulates the in vivo growth 
behavior of malignant prostate cancer cells, specifically PC-3 cells, through construction 
of an in vitro bone metastatic prostate cancer microenvironment. 
 
To develop a supportive metastatic prostate cancer model, we hypothesized that it 
would be crucial to culture the cells in 3D along with the surrounding cells in the 
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microenvironment that the metastatic prostate cancer cells reside in (Abbott 2003; 
Griffith and Swartz 2006; Yamada and Cukierman 2007).  For example, cells are known 
to proliferate at a much slower rate that is more physiological when cultured in 3D than 
2D (Mueller-Klieser 1997; Torisawa et al. 2005; Hotary et al. 2003).  It is also known 
that prostate cancer cells not only proliferate differently when co-cultured with other 
stromal cells or fibroblasts, but can also affect the proliferation rates of the other cell 
types under various in vitro and in vivo models (Camps et al., 1990; Yang et al. 2001; 
Barrett et al. 2005).  We adopted co-culture spheroids as a 3D prostate cancer niche 
model. 
 
Spheroids are sphere-shaped cell colonies formed by self-assembly that allow 
various growth and functional studies of diverse tisues (Ingram et al. 1997).  Spheroids 
serve as excellent physiologic tumor models as they mimic avascular tumors and 
micrometastases (Klob et al. 2008) and are known to provide more reliable and 
meaningful therapeutic readouts (Kunz-Schughart et al. 2004).  Although these 
advantages of tumor spheroids has been widely recognized (Kelm and Fussenegger 2004), 
challenges involved in the tedious procedures requid for formation, maintenance, 
solution exchange, and microscale cell and fluid manipulation are still holding back the 
industry from using the well-validated spheroid tissue model more widely. 
 
Formation of spheroids occurs spontaneously, in enviro ments where cell-cell 
interaction dominates over cell-substrate interactions.  Typical methods for spheroid 
generation include hanging drops, culture of cells on non-adherent surfaces, spinner flask 
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cultures, and NASA rotary cell culture systems (Lin a d Chang 2008; Friedrich et al. 
2007).  Recently, various groups have also developed s heroids on a chip works utilizing 
microscale technologies such as microwell arrays and microfluidic devices (Torisawa et 
al. 2007; Wu et al. 2008; Toh et al. 2007; Fukuda et al. 2006; Ungrin et al. 2008; Leclerc 
et al. 2004; Mori et al. 2008).  There have also been spheroid co-culture wo ks including 
co-culture of endothelial cells with fibroblasts and smooth muscle cells using hanging 
drops (Kelm and Fussenegger 2004; Korff et al. 2001; Kelm et al. 2005).  Metastatic 
prostate cancer cell line PC-3 cells have been co-cultured with fibroblasts using the 
NASA rotary cell culture system (Ingram et al. 1997).  Many of these techniques, 
however, suffer from problems such as efficiency of forming spheroids, long-term culture, 
control of spheroid size, and uniform distribution f small numbers of co-culture cell 
types across all spheroids.  Here, we apply a microfluidic spheroid formation technology 
used previously to form embryoid bodies (Torisawa et al. 2007) to the formation of 
heterogeneous co-culture spheroids of PC-3’s supported by osteoblasts and endothelial 
cells as a model of the niche microenvironment for pr state cancer metastasis to the bone. 
 
 
2.2 Materials and Methods 
 
2.2.1 General Cell Culture 
 
The PC-3 prostate cancer cells originally isolated from vertebral metastases in 
prostate cancer patient were obtained from ATCC (Rockville, MD).  PC-3 cells were 
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stably transfected via DsRed lentivirus (LG501, Biogenova, Rockville, MD) following 
manufacturer’s protocol.  After transfection cells were sorted by flow cytometry for the 
brightest 10% of the population.  PC-3 cells that st bly express the DsRed protein are 
denoted as PC-3DsRed cells.  PC-3DsRed cells were compared to PC-3 cells for several 
passages and were shown to behave normally.  PC-3DsRed cells were cultured in T-25 
flasks (Corning, Acton, MA) and maintained in complete media consisting of RPMI-
1640 (61870; Gibco) supplemented with 10% (v/v) fetal bovine serum (FBS; 10082; 
Gibco), and 1% (v/v) penicillin-streptomycin (Invitrogen).  The PC-3DsRed cells were 
routinely passaged at 70-90% confluence.   
 
Human umbilical vein endothelial cells (HUVECs, Lonza) passage number 2-6 
were cultured in endothelial growth medium-2 (EGM-2, Lonza) in T-25 flasks.  The 
HUVECs were collected by washing and detaching with 0.25% trypsin/EDTA 
(Invitrogen).  The trypsin solution was neutralized with 10% FBS in DMEM (Invitrogen) 
and spun down with a centrifuge (ThermoForma, Marietta, OH) for 5 min at 4oC and 
resuspended in EGM-2.  The spin and resuspension in EGM-2 were repeated to ensure 
removal of trypsin.   
 
MC3T3-E1 cells are pre-osteoblasts derived from murine calvarias.  When treated 
with ascorbate, these cells express osteoblast-specific markers and are capable of 
producing a mineralized matrix (Franceschi and Iyer 1992; Franceschi et al. 1994).  
These cells were routinely maintained in α-MEM (Alpha Minimum Essential Medium; 
Gibco) supplemented with 15% (v/v) FBS, and 1% (v/v) penicillin-streptomycin.  
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Differentiation of MC3T3-E1 cells into osteoblasts was only induced when cultured as 
spheroids by addition of 50 µg/ml ascorbic acid.  All cultures were maintained in a 
humidified incubator at 37oC, 5% CO2, and 100% humidity. 
 
2.2.2 Fabrication of Microfluidic Devices and Cell Seeding 
 
The microfluidic device consists of a two-layer poly(dimethylsiloxane) (PDMS) 
device with two microchannels separated by a semi-permeable polycarbonate membrane 
(Figure 2.1).  The upper channel consists of 28 side-chambers and is a dead-end designed 
to facilitate cell capture, whereas the lower channel is continuous to allow for media 
perfusion.  The semi-permeable polycarbonate membrane was 10 µm thick with 5 µm 
pores with low cellular attachment (TMP04700; Fisher).  Spheroids are cultured on the 
upper channel while the lower channel contains cell culture media.  The fabrication of the 
device is as previously described (Torisawa et l. 2007).  The lower channel is 100 µm in 
height and 2 mm in width.  The dimensions of each cuboidal shaped side-chamber in the 
upper channel are 200 x 200 x 200 µm, while the central microchannel cross sectional 
area is 200 µm in height and 50 µm in width.   
 
Microchannel and membrane surfaces are treated with 1% w/v Pluronic F108 
(BASF) overnight to be resistant to cell adhesion.  Before seeding cells, co-culture media 
consisting of PC-3 complete growth media and 50 µg/ml ascorbic acid was introduced 
into the device and incubated for 1 hr.  Pre-mixed h terogeneous cell suspensions at 
1:50:50 PC-3DsRed:HUVEC:MC3T3-E1 ratio were then introduced into theupper channel 
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using gravity-driven flow.  Specifically, the tube connected to the outlet of the lower 
channel was lowered to approximately 15 cm below the inlet reservoir during the cell 
seeding process.  Consequently, gravity resulted from this height difference between the 
reservoirs created a suction force through the lower channel that facilitates uniform 
seeding of a confluent monolayer of cells in the upper channel.  The cells were cultured 
under static conditions with daily media exchange through the lower channel. 
 
2.2.3 PC-3DsRed Proliferation Tracking and Evaluation of Viability 
 
Co-culture spheroids that formed in the microchannel w re imaged by phase 
contrast microscopy as well as fluorescence microscopy (Nikon TE-300).  The number of 
PC-3DsRed cells within each spheroid was tracked by fluorescence everyday for a total of 7 
days.  On the last day (day 7) of culture, the spheroids were stained with calcein-AM 
(Invitrogen) to evaluate cellular viability.  Calcein-AM dissolved in PBS to a final 
concentration of 1µg/ml was introduced into both the upper and lower channels and 
incubated for 30 min at 37oC.  Cross-sections of the co-culture spheroids were 
subsequently imaged by confocal microscopy. 
 
2.2.4 Doubling Time Calculation 
 
 PC-3DsRed doubling time calculation for the co-culture spheroids inside devices 
(3D co-culture in device) was calculated by first fitting an exponential-fit line through the 
average data points from the PC-3DsRed proliferation graph (Figure 2.2e,  average number 
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of PC-3DsRed cells/spheroid vs. time).  The equation obtained from the fit was y = 
3.1679(e0.0707t) with r2 = 0.9041.  We subsequently set y = 6 (two times th initial average 
of PC-3DsRed cells per spheroid on day 1) and solved for t (forthe time it takes for the 
initial number of PC-3DsRed cells at day 1 to double).  The final doubling time equals t – 
24 (the time it takes for the PC-3DsRed cells present at day 1 to double).  The same method 
was used to calculate the doubling time of PC-3DsRed co-culture spheroids cultured on 96 
well plates (3D co-culture in dish).   
 
For PC-3 doubling time calculation under 2D mono-culture in dish, 2D co-culture 
in dish, and 3D mono-culture in dish (non-adherent culture), the initial and final number 
of cells were counted and the doubling time was solved from the equation N(t) = N(t0) 
2[(t-t0)/D] where N(t) = number of cells at time t (final number of cells), N(t0) = number of 
cells at time to (initial number of cells), t = harvesting time, t0 = plating time, t-t0 = time 
the cells have had to grow, and D = doubling time.  The doubling time is reported in 
hours. 
 
2.2.5 Spheroid Size Measurements 
 
 The size of the co-culture spheroids formed within the microchannel was 
determined by measuring their diameters as previously described (Torisawa et al. 2007).  
Co-culture spheroids that formed in the microchannel w re imaged by phase contrast 
microscopy as described above.  The mean diameter (d) of the co-culture spheroids was 
determined using the following equation: d = (a x b)1/2, where a and b are orthogonal 
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diameters of the spheroid (Kelm et al. 2003).  The average size of the co-culture 
spheroids was reported as mean diameter ± standard deviation. 
 
2.2.6 2D Co-culture, 3D Mono-culture, and 3D Co-cult re in Dish 
 
 For the 2D co-culture experiment, HUVEC and MC3T3-E1 cell suspensions were 
pre-mixed at a 1:1 ratio.  The heterogeneous cell mixture of HUVEC and MC3T3-E1 
cells (support cells) were subsequently plated as a confluent monolayer on a tissue 
culture dish.  24 hours later when HUVEC and MC3T3-E1 cells had already attached to 
the tissue culture dish, PC-3DsRed cells were added on top of the confluent monolayer of 
support cells at a co-culture ratio of 1 PC-3DsRed to 100 support cells.  The cells were 
maintained in co-culture media consisting of PC-3 complete growth media and 50 µg/ml 
ascorbic acid.  Culture media were changed daily as in our co-culture spheroid system.  
The 2D co-culture system was monitored everyday for a total of 6 days.  On the last day 
of culture (day 6), live stain (calcein-AM dissolved in PBS to a final concentration of 
1µg/ml) was performed to determine the viability of the PC-3DsRed cells. 
 
 For the culture of PC-3 cells on non-adherent surface as a model for closely 
aggregated 3D mono-culture, PC-3 cells were seeded in ultra-low attachment 96-well 
plates (Corning Costar) at a density of 5000 cells/well.  PC-3 cells were maintained in 
PC-3 complete growth media and monitored for a total f 5 days.  On the last day of 
culture (day 5), live/dead stain (calcein-AM and ethidium homodimer-1 dissolved in PBS 
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to a final concentration of 1µg/ml) was performed to determine the viability of the PC-
3DsRed cells. 
 
 For the culture of PC-3DsRed co-culture spheroids on non-adherent dish, pre-mixed 
heterogeneous cell suspensions at 1:50:50 PC-3DsRed:HUVEC:MC3T3-E1 ratio were first 
formed into 30 µl hanging drops with ~500 cells/drop.  After 1 day in culture when PC-
3DsRed co-culture spheroids were formed, each spheroid was then transferred to each well 
in a non-adherent 96-well plate.  PC-3DsRed co-culture spheroids were maintained in co-
culture media consisting of PC-3 complete growth media and 50 µg/ml ascorbic acid and 
monitored over 7 days.  Half of the total volume of culture media was exchanged by fresh 
media daily. 
 
2.2.7 PC-3DsRed CD133+ Cell Sorting 
 
PC-3DsRed CD133+ cells were isolated using CD133 Cell isolation kit, according to 
the manufacturer’s protocol (Miltenyl Biotec).  Briefly, cells were made into single cell 
suspension by using cellstripper (Mediatech, Inc., VA), washed with PBS and 
resuspended into MACS Buffer supplemented with 0.5% BSA.  The cells were labeled 
with CD133 microbeads for 30 minutes after blocking Fc receptors with FcR Blocking 
reagent.  After labeling, the cells were washed with MACS buffer.  Magnetically labeled 
CD133 positive cells were passed through LS columns (Miltenyl Biotech).  Cells were 





2.3 Results and Discussion 
 
2.3.1 Formation of PC-3DsRed Co-culture Spheroids within Microchannel (Spheroid 
Size, Media Exchange, Distribution of PC-3DsRed Cells) 
 
A schematic of the microfluidic device comprised of two microchannels separated 
by a semi-permeable membrane is shown in Figure 2.1a, b.  The PC-3DsRed co-culture 
spheroids form through a process shown in Figure 2.1c.  Heterogeneous cell mixture of 
PC-3DsRed, MC3T3, and HUVEC cells at 1:100 PC-3DsRed to support cells ratio was 
introduced into the upper channel as a monolayer.  Since the microchannel surfaces were 
rendered resistant to cell adhesion, the cells self-aggregated to form co-culture spheroids 
within 1 day in culture.  Figure 2.1d shows the actu l images of the co-culture spheroid 
formation process.  Despite the dead-end upper channel, cells could still be introduced 
into the upper channel through gravity-driven seeding with suction from the lower 
channel through the semi-permeable membrane.  Furthermore, due to the circular flow 
pattern inside the cuboidal-shaped side-chambers (Figure 2.1c), the cells preferentially 
settled into the side chambers and tended to aggregate into circular shapes during seeding.  
Such automatic formation of semi-aggregated cellular m ss during the seeding process 
facilitated the subsequent spheroid formation.  Thesiz s of the spheroids were relatively 
uniform and synchronous in their formation.  The ara of each side chamber as dictated 
by the microchannel size specification provided control of uniformly-sized spheroids.  In 
our device, the area of each side chamber (200 µm by 200 µm) was 4 x 104 µm2.  Since 
the size of each cell was about 10 µm in height, the estimated volume of a confluent 
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monolayer of rounded, unattached cells in each chamber was approximately 4 x 105 µm3.  
To achieve this volume, the estimated diameter of each spheroid would have to be 90 µm, 
which was approximately the size of the spheroids that we consistently obtained in our 
experiments (86 ± 12 µm).  The microchannel size specifications can easily be adjusted to 
allow uniform spheroid formation of various other sizes (Torisawa et al. 2007).  In 
addition, the compartmentalization afforded by the 5 µm semi-permeable polycarbonate 
membrane allowed convenient exchange of media from the bottom channel while non-
attached spheroids were cultured on the top channel without perturbation of the spheroid 
positions and convective washout.  The side-chamber design further introduced 
compartmentalization to keep co-culture spheroids stationary for easy continuous PC-
3DsRed cell tracking despite daily culture media exchange. 
 
 In order to track and monitor the small number of prostate cancer cells within co-
culture spheroids, we used PC-3 cells stably transfected with the fluorescent protein 
DsRed (PC-3DsRed).  PC-3DsRed cells were co-cultured with osteoblasts (MC3T3-E1), and 
endothelial cells (HUVEC) in the microfluidic device to mimic a “niche”-like 
microenvironment.  The choice of support cells was b ed on the fact that PC-3 cells 
were first isolated from prostate cancer metastasis to the bone.  Furthermore, it has been 
suggested that the process of prostate cancer metastasis to the bone is similar to the 
homing of HSC’s to the bone marrow (Taichman et al. 2007; Shiozawa et al. 2008; 2010).  
Prostate cancer cells that successfully established metastasis at the bone marrow seem to 
parasitize the HSC niche and harvest the normal machinery from the niche 
microenvironment to facilitate growth and survival (Taichman et al. 2007; Shiozawa et al. 
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2008; 2010).  To mimic this HSC niche for prostate cancer cell culture, we chose a co-
culture cell ratio of 1:100 PC-3DsRed to support cells, which had previously been shown to 
yield the best supporting niche microenvironment for HSC’s (unpublished results).  
Figure 2.1e shows an image of PC-3DsRed co-culture spheroid.  The PC-3DsRed cells were 
red while green represented live cells (calcein-AM live stain).  The PC-3DsRed cells were 
clearly distinguished from all the other support cells by its red fluorescence.  The spatial 
arrangement of the PC-3DsRed cells within the spheroid was relatively random, with PC-
3DsRed cells located everywhere throughout the spheroids.  Our microfluidic device was 
able to ensure the incorporation of small numbers of PC-3DsRed cells inside co-culture 
spheroids with intimate contact with the support cells.  In addition, the distribution of PC-
3DsRed’s across all spheroids in the device was relatively uniform.  Since 10,000 cells 
were introduced into the device that consists of 28 side-chambers, the initial number of 
cells in each chamber was about 350 cells/chamber.  At the co-culture ratio of 1 PC-
3DsRed to 100 support cells, the theoretical number of PC-3DsRed’s was 3.5 cells/chamber.  
This was in good agreement with the number we obtained in our experiments with an 
average of 3 ± 2 cells/spheroid on day 1 in culture.  Except the three chambers at the 
dead-end of the device in which there were fewer cells seeded overall, PC-3DsRed cells 
were uniformly distributed along the length of the device at the consistent co-culture ratio 
of 1 percent.  Uniform distribution of the PC-3DsRed cells across all co-culture spheroids 
allows for a consistent pool of 3D tissue samples for a wide variety of applications such 
as anti-cancer drug sensitivity testing experiments. 
 




The PC-3DsRed cells were tracked for their proliferation within each spheroid by 
their fluorescence everyday for a total of 7 days.  The growth pattern and viability of the 
PC-3DsRed cells within the 3D co-culture environment over the course of 1 week is shown 
in Figure 2.2.  Figure 2.2a, b, c show the optical and fluorescent time-lapse images of PC-
3DsRed cells cultured within MC3T3 and HUVEC co-culture spheroids.  In this particular 
co-culture spheroid, there was only one PC-3DsRed cell on day 1 of culture, which 
gradually proliferated into two cells by day 4, and again doubled to four cells by day 7.  
This showed that PC-3DsRed cells were still able to proliferate inside co-culture spheroids.  
PC-3DsRed cells were still alive after 7 days in culture inside spheroids as shown in Figure 
2.2d with a representative section of the PC-3DsRed co-culture spheroid obtained using 
confocal microscopy.  Live cells were stained with calcein-AM and appeared to be green 
while PC-3DsRed cells expressed red fluorescence.  Since all the red cells co-localize with 
the viable green color, all the PC-3DsRed cells were able to survive under the 3D co-culture 
environment after 7 days in culture.  Together, these results demonstrated that PC-3DsRed 
cells were able to survive and proliferate inside oste blast and endothelial cell co-culture 
spheroids.  As shown in Figure 2.2e, PC-3DsRed’s mainly remained quiescent and 
proliferated at a relatively slow rate in 3D co-culture environment.  PC-3DsRed cells 
merely proliferated from an average of 3 cells/spheroid to an average of 5 cells/spheroid.  
The doubling time of the PC-3DsRed cells under the 3D co-culture environment was 
estimated to be 212 h (about 9 days, Table 2.1).  Such proliferation rate of PC-3DsRed cells 
inside spheroids is much slower than the conventional 2D mono-culture (doubling time ≈ 
24 h, Table 2.1).  Although the in vivo metastatic prostate cancer cell proliferation rateis 
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not exactly known, we believe that our prostate cancer cell co-culture spheroid system 
mimicking the in vivo prostate cancer cell niche microenvironment more faithfully 
recapitulated a reasonable physiologic growth pattern of prostate cancer cells in vitro.  
The in vivo doubling time of PC-3 cells was roughly determined to be between 1 to 2 
weeks from various PC-3 in vivo culture experiments (Nakanishi et al. 2003; Singh et al. 
2004; Li et al. 2008), which was in good agreement with the observed PC-3DsRed doubling 
time in our in vitro microfluidic 3D spheroid co-culture system. 
 
 Since we have previously demonstrated that cells can be cultured normally inside 
a membrane-type device (Torisawa et al. 2007; Huh et al. 2007), the device should not 
affect cellular proliferation.   We cultured PC-3DsRed co-culture spheroids on non-adherent 
dishes to confirm their proliferation behavior.  Proliferation rate of PC-3DsRed cells 
cultured on non-adherent dishes (doubling time ≈ 205 hrs, Table 2.1) was very similar to 
that cultured inside devices.  Since a hanging dropmethod is difficult to culture spheroids 
for a week because of difficulty of changing culture media, and also non-adherent dish 
culture is difficult to monitor each spheroid because of aggregation of spheroids, 
spheroids were made by the hanging drop method and e ch spheroid was then transferred 
to each well in a non-adherent 96-well plate.  The fact that the PC-3DsRed cells proliferated 
at a considerably slower rate inside the co-culture spheroids was not device-dependent.  
Rather, the proliferation of cells inside these two-layer semi-permeable membrane 
devices seem to be cell type-dependent as other cell typ s cultured under both 2D and 3D 




We compared PC-3DsRed proliferation in our co-culture spheroid system to 2D co-
culture in dishes.  PC-3DsRed, HUVEC and MC3T3-E1 cells were co-cultured under 2D 
dish environment at 1:100 PC-3DsRed to support cells ratio and PC-3DsRed proliferation was 
monitored everyday for a total of 6 days.  On day 1 of culture, there were very few PC-
3DsRed cells present (Figure 2.3a, b).  But by day 6, it was clear that the PC-3DsRed cells 
had proliferated extensively (Figure 2.3e, f), with an estimated doubling time of ≈ 29 hrs 
(Table 2.1).  Furthermore, viability experiments confirmed that most of these actively 
proliferating PC-3DsRed cells were still alive on day 6 (data not shown).  These results 
demonstrated that the complex interplay of various soluble factors involved in prostate 
cancer and support cells co-culture was not enough to mimic the physiologic 
microenvironment.   This finding also implied that mere cell-cell interaction in a 2D 
context between PC-3DsRed cells and support cells was not sufficient to recapitulate a 
physiologic proliferation rate of the prostate cancer ells.  Therefore, a physiologic 
microenvironment not only involves cell-cell interaction, but 3D environment is also a 
critical factor. 
 
We also compared PC-3DsRed 3D co-culture spheroid inside the device to PC-
3DsRed 3D mono-culture inside the same device.  Instead of introducing heterogeneous 
mixture of the co-culture cells into the device, pure PC-3DsRed cells were seeded.  PC-
3DsRed cells did not form spheroids but quickly aggregated into cell clusters within one 
day of culture.  Over 7 days of culture, it was clear that the PC-3DsRed cells proliferated 
under such 3D mono-culture environment inside the device (data not shown).  However, 
because it is difficult to quantify the number of PC-3DsRed cells inside the device, we 
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estimated the PC-3DsRed doubling time under 3D mono-culture condition by investigating 
the effect of blocking cell-substrate attachment on PC-3 cells.  Initially, PC-3 cells were 
seeded in ultra-low attachment 96-well plates at a density of 5000 cells/well.  PC-3 cells 
quickly aggregated into cell clusters of various size  within 1 day in culture (Figure 2.3g), 
but they did not form spheroids.  Nevertheless, such close-packed, non-adherent culture 
condition resembled PC-3 3D mono-culture in dish.  Over the 5 days of culture, PC-3 
cells still proliferated at a comparative rate (doubling time ≈ 36 h, Table 2.1) as the 
normal 2D mono-culture condition (Figure 2.3h).  In addition, almost all PC-3 cells were 
still alive after 5 days in culture as demonstrated by live/dead stain (Figure 2.3i).  This 
showed that PC-3 mono-culture under such closely-aggregated 3D-like environment was 
still not sufficient in recapitulating a more physiological growth rate of prostate cancer 
cells.  Various PC-3-support cells interaction may be imperative in inducing the more 
physiological proliferation of PC-3DsRed cells under the 3D co-culture spheroid condition.  
One other interesting characteristic of our co-culture spheroids was that the support cell 
did not seem to be proliferating.  This was a desired characteristic as the endothelial cells 
and osteoblasts mainly function to support the PC-3DsRed cells without depleting the 
nutrients in the microenvironment. 
 
In summary, under normal 2D mono-cultures, PC-3DsRed, HUVEC, and MC3T3-
E1 cells all proliferated at a relatively fast rate.  When grown as 3D mono-cultures, PC-
3DsRed, HUVEC, and MC3T3-E1 cells proliferated, died, and stayed relatively quiescent, 
respectively.  When all three cell types are co-cultured in 2D, there seemed to be 
proliferation of all three cell types.  But interestingly, co-culture of all three cell types in 
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3D seemed to be no death of the HUVECs, quiescence of the MC3T3-E1 cells, and slow 
proliferation of the PC-3DsRed cells.  These non-additive synergistic effects of co-culture 
contributed to a stable co-culture system, which contrasts with rapid proliferation of PC-3 
cell mono-cultures in 2D and 3D, with the rapid proliferation in 2D but death of 3D 
spheroids of endothelial cell mono-cultures, and with rapid proliferation in 2D but slow 
growth of 3D spheroids of osteoblasts.  Such cellular behavior may be a combination of 
effects from various soluble and insoluble factors, direct heterotypic cell-cell interactions 
between PC-3DsRed and support cells in a semi-confined 3D context, and the unique 
extracellular matrix (ECM) composition contributed by all co-culture cell types leading 
to various proliferation inhibitory and survival eff cts through integrin signaling.  
Various other co-culture examples also exhibit promoting effects from support cells as 
well as synergistic cross-talk between co-culture cell types (Camps et al. 1990; Korff et 
al. 2001; Kelm et al. 2005).  The results highlight the importance of culturing cells not 
only in 3D but also with appropriate co-culture of cells. 
 
2.3.3 CD133+ PC-3DsRed Co-culture Spheroids 
 
CD133 is a potential marker for prostate cancer stem c ll (CSC), and therefore the 
CD133+ population is believed to be enriched for CSCs.  The 3D co-culture spheroid 
system was therefore also applied to CD133+ PC-3DsRed cells.  Figure 2.4a, b, c shows the 
time-lapse images of CD133+ PC-3DsRed cell co-culture spheroids with MC3T3-E1 and 
HUVEC at 1:100 CD133+ PC-3DsRed cells to support cells ratio.  In this particular co-
culture spheroid, the only CD133+ PC-3DsRed cell present on day 1 (Figure 2.4a) did not 
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proliferate inside the spheroid throughout the 7 days of culture (Figure 2.4b, c).  The 
same cell was kept alive but quiescent inside the sp roid for a week.  Figure 2.4d shows 
the graph of the overall CD133+ PC-3DsRed cell proliferation pattern inside co-culture 
spheroids over 7 days.  There seemed to be a slight decreasing trend in the average 
number of CD133+ PC-3DsRed cells per spheroid over the first 4 days.  This might be due 
to the fact that a greater number of cells were dying in the first few days as these CD133+ 
PC-3DsRed cells might have been stressed more during the sorting process.  The remaining 
viable cells seemed to stay quiescent or start to proliferate slowly.  The greater variability 
in the CD133+ PC-3DsRed cell proliferation and survival between different spheroids also 
explains the larger standard deviation seen on day 4 nd day 7 of culture.  Overall, the 
CD133+ PC-3DsRed cells cultured inside co-culture spheroids supported by HUVEC and 
MC3T3-E1 cells were able to survive but did not proliferate much over the course of 1 
week. 
 
Under traditional 2D mono-culture condition, these CD133+ PC-3DsRed cells can 
easily differentiate to loose their cell surface marker.  In our 3D co-culture spheroid 
system, the CD133+ PC-3DsRed cells remained mostly quiescent without much 
proliferation.  Further experiments are needed to characterize in more detail the survival, 
proliferation, and the maintenance of the CD133 marker in these cells.  The type and ratio 
of supporting cells used may also be critical for maintaining the cell surface marker of 
these cells.  Nevertheless, our system demonstrated a unique culture method that may be 
able to capture the CD133+ population of PC-3’s at the quiescent stage.  Such model 
would be suitable for the development of anti-cancer drugs that target CSCs.  As 
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mentioned earlier, new therapeutics that specifically t rget CSCs are much needed, but 
currently it has been extremely difficult to maintai  and culture CSCs in vitro.  Our 
microfluidic 3D co-culture spheroids system efficiently provides physiologic 3D prostate 
cancer and CSC tissue constructs as models for anti-c cer drug sensitivity testing on the 





We describe the design and fabrication of a platform for efficient microfluidic 3D 
co-culture of metastatic prostate cancer cells within a “niche”-like construct.  In addition 
to promoting reliable formation of uniformly-sized spheroids, our system also ensures 
uniform distribution of the small number of PC-3 cells as well as the other co-culture cell 
types across all spheroids within the device.  In addition, the side-chamber microchannel 
design keeps the spheroids stationary during media exchange for easy tracking of the PC-
3’s during extended longer term cultures.  Using these capabilities, we created 3D cancer 
“niche”-like microenvironments with high cell viability and a more physiological slower 
growth behavior of prostate cancer cells.  The micros ale 3D tumor tissue constructs may 
be valuable as a model for testing drugs that targe the cancer microenvironment as well 
as the cancer cells themselves in their more quiescent state in the niche.  Although this 
paper focused on prostate cancer cells and their niche, the technology described is 
versatile and should be readily applicable for culture of various other types of cells in a 
physiological 3D setting. 
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Figure 2.1.  Schematic illustrations of the microfluidic spheroid formation device design 
(a) to (b) and PC-3DsRed co-culture spheroid formation process (c).  The device consists of 
two PDMS microchannels separated by a semi-permeable polycarbonate membrane with 
5 µm pores.  The upper channel is a dead end channel with 28 side-chambers to culture 
spheroids, and the lower channel has flow through capability for culture medium.  Before 
seeding cells, the channel and membrane surfaces are rendered resistant to cell adhesion.  
The heterogeneous mixture of PC-3DsRed and support cells (MC3T3-E1 and HUVEC) at 
1:100 co-culture ratio are introduced into the upper channel as a confluent monolayer.  
The cells preferentially settle inside the side-chambers and self-aggregate to form PC-
3DsRed co-culture spheroids within 1 day of culture. (d) Actual time-lapse images of PC-
3DsRed co-culture spheroid formation within microchannel (side-chambers: 200 x 200 x 
200 µm, central microchannel: 50 µm width, 200 µm height).  Optical images were taken 
immediately after seeding and 1 day after introducing the cells. (e) Optical and 
fluorescent images of a PC-3DsRed co-culture spheroid after 1 day of cultlure in the 
microfluidic device.  Red = PC-3DsRed cells, Green = MC3T3 and HUVEC (support cells).  








Figure 2.2.  Time-lapse images of PC-3DsRed cell proliferation within HUVEC and 
MC3T3-E1 co-culture spheroid in side-chambers of the microfluidic device.  Optical 
images of the co-culture spheroids and fluorescent images of PC-3DsRed cells on day 1 (a), 
day 4 (b), and day 7 (c) of culture.  (d) A confocal section of PC-3DsRed co-culture 
spheroid illustrating the viability of PC-3DsRed cells.  Red = PC-3DsRed cells, Green = Live 
cells (Calcein-AM stain), Yellow = Live PC-3DsRed cells.  (e) Graph of PC-3DsRed 
proliferation pattern inside co-culture spheroids over a course of 1 week.  Y-axis shows 
the average number of PC-3DsRed cells per spheroid (error bars are standard error), x-axis 




Figure 2.3.  Time-lapse images of PC-3DsRed proliferation under 2D co-culture with 
MC3T3-E1 and HUVEC (a) to (f).  Red = PC-3DsRed cells.  Time-lapse images of PC-3 
proliferation on non-adherent surface (g) and (h) and day 5 viability (i).  Red = dead cells, 
Green = live cells.  Scale bar is 200 µm. 
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Figure 2.4.  Time-lapse images of PC-3DsRed CD133+ cell proliferation within HUVEC 
and MC3T3-E1 co-culture spheroid in side-chambers of the microfluidic device.  Optical 
images of the co-culture spheroids and fluorescent images of PC-3DsRed CD133+ cells on 
day 1 (a), day 4 (b), and day 7 (c) of culture.  (d) Graph of PC-3DsRed CD133+ cell 
proliferation pattern inside co-culture spheroids over a course of 1 week.  Y-axis shows 
the average number of PC-3DsRed CD133+ cells per spheroid (error bars are standard error), 
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High-throughput 3D Spheroid Culture and Drug Testing Using a 384 
Hanging Drop Array 
 
Culture of cells as three-dimensional (3D) aggregats can enhance in vitro tests 
for basic biological research as well as for theraputics development.  Such 3D culture 
models, however, are often more complicated, cumbersome, and expensive than two-
dimensional (2D) cultures.  This chapter describes a 384-well format hanging drop 
culture plate that makes spheroid formation, culture, and subsequent drug testing on the 
obtained 3D cellular constructs as straightforward to perform and adapt to existing high-
throughput screening (HTS) instruments as conventional 2D cultures.  Using this 
platform, we show that drugs with different modes of action produce distinct responses in 
the physiological 3D cell spheroids compared to conventional 2D cell monolayers.  
Specifically, the anti-cancer drug 5-fluorouracil (5-FU) has higher anti-proliferative 
effects on 2D cultures whereas the hypoxia activated drug commonly referred to as 
tirapazamine (TPZ) are more effective against 3D cultures.  The multiplexed 3D hanging 
drop culture and testing plate provides an efficient way to obtain biological insights that 





Three-dimensional (3D) cell culture is motivated bythe need to work with 
cellular models that better mimic physiological tissues.  Cellular functions and responses 
that are present in tissues are often lost in conventional ‘dish’-based two-dimensional (2D) 
cell cultures limiting predictive capability of drug assays and skewing cell biological 
research results (Pampaloni et al. 2007).  Consequently, many researches have been 
devoted to develop in vivo-like 3D cell culture techniques.  Spheroid formation s one of 
the most well characterized models for 3D culture and screening due to its simplicity, 
reproducibility, and similarity to physiological tissues compared to other methods 
involving extracellular matrix (ECM) scaffolds and hydrogel systems (Friedrich et al. 
2009; Kunz-Schughart et al. 2004).  Spheroids are self-assembled spherical clusters of 
cell colonies cultured in environments where cell-c interactions dominate over cell-
substrate interactions, and they naturally mimic avascular tumors with inherent metabolic 
(oxygen) and proliferative (nutrient) gradients (Fried ich et al. 2009; Kunz-Schughart et 
al. 2004).  Therefore, spheroids serve as excellent physiologic tumor models known to 
provide more reliable and meaningful therapeutic readouts compared to 2D tests (Kunz-
Schughart et al. 2004).  Spheroids allow cellular self-organization f appropriate 3D 
ECM assembly with complex cell-matrix and cell-cell interactions that mimic functional 
properties of the corresponding tissue in vivo (Friedrich et al. 2009).  Most importantly, 
spheroids can be monitored easily for practical daily observations. As a result, spheroid 
cultures have been valued as a physiologically relevant alternative to 2D cultures for 




Although these advantages of spheroids have been widely recognized, it has been 
difficult to scale up spheroid culture in a high-throughput manner for screening and 
testing.  Typical spheroid formation methods include hanging drops on the underside of 
culture plate lids, culture of cells on non-adherent surfaces, spinner flask cultures, and 
rotary cell culture systems (Friedrich et al. 2007).  These traditional spheroid formation 
and culture systems, however, are often tedious, low-throughput, hard to handle, and 
produce variable size spheroids.  Recently, various microfluidic (spheroids on a chip) 
devices have also been developed (Torisawa et l. 2007; Sakai and Nakazawa 2007; 
Ungrin et al. 2008; Lee et al. 2010; Torisawa et al. 2007; Wu et al. 2008; Toh et al. 2007; 
Fukuda et al. 2006) to increase spheroid formation efficiency, offer better control of 
spheroid sizes, as well as simplify handling procedur s.  Many of these techniques, 
however, still suffer from problems such as long-term culture and device compatibility 
with drugs.  Most importantly, these techniques are oft n not compatible with existing 
liquid handling robots for performing high-throughput screening (HTS).  In this chapter, 
we describe a 384-well format spheroid culture plate based on the scientifically proven 
but traditionally tedious hanging drop method.  The d veloped hanging drop array 
platform allows for efficient formation of uniformly-sized spheroids, their long-term 
culture, and drug testing using existing HTS instruments (e.g. liquid handling robots and 
plate readers) (Figure 3.1d).  Utilizing this platform, we show that drugs with different 
modes of action produce distinct responses in the pysiological 3D cell spheroids 





3.2 Materials and Methods 
 
3.2.1 Plate Design, Fabrication, and Hanging Drop Formation 
 
The hanging drop array plate is made of polystyrene, a d fabricated by injection 
molding.  To overcome the drawback in liquid handlig and substrate inversion of the 
conventional hanging drop method, each cell culture site has an access hole (diameter = 
1.6 mm) through the substrate with a plateau on the bottom surface (diameter = 3mm, 
height = 0.5 mm) (Figure 3.1a).  These cell culture sit s are arranged in the standard 384-
well plate format (16 rows, 24 columns, and 4.5 mm apart in both directions as shown in 
Figure 3.1b).  To alleviate the commonly encountered evaporation problem with the 
small volume hanging drops (tens of µl), a water reservoir is constructed around the 
periphery of the culture sites (Figure 3.1a, b, e).  
 
Prior to usage, a hydrophilic coating (0.1%, Pluronic F108, BASF Co., 
Ludwigshafen, Germany) is applied onto the entire plate surface.  The plate is 
subsequently UV sterilized before cell seeding.  To form hanging drops, cell suspension 
solution is pipetted from the top side through the access holes with the end of each pipette 
tip inserted into the access hole to guide the sample liquid to the bottom surface (Figure 
3.1c).  The liquid or cell samples can also be removed from the drop through the access 
holes using pipettes or slot pins (V&P Scientific, Inc., San Diego, CA).  The size of the 




3.2.2 General Cell Culture 
 
To investigate the stability of long-term hanging drop spheroid culture using the 
designed array plate, osmolality measurements were p formed while culturing three 
types of cells:  African green monkey kidney fibroblast cell (COS7), murine embryonic 
stem (mES) cell (ES-D3), and human epithelial carcinoma cell that stably express 
mesothelin (A431.H9) cell (Ho et al. 2005).  Prior to performing hanging drop culture 
using the plate, ES-D3 cells were cultured in dishes coated with 0.1% w/v porcine gel 
(Sigma-Aldrich Co.) and maintained in medium consisting of Dulbecco’s Modified 
Eagle’s Medium (DMEM) (Gibco 11960, Invitrogen Co., Carlsbad, CA) with 15% v/v 
fetal bovine serum (FBS) (Gibco 10082, Invitrogen Co.), 4 mM L-glutamin (Invitrogen 
Co.), 0.1mM 2-mercapto-ethanol (Sigma-Aldrich Co.), 0.02% v/v sodium pyruvate 
(Sigma-Aldrich Co.), 100 U/ml penicillin (Invitrogen Co.), 100 U/ml streptomycin 
(Invitrogen Co.), and 1000 U/ml ESGRO (Invitrgoen Co.) which contains leukemia 
inhibitory factor (LIF).  COS7 and A431.H9 cells were cultured in DMEM (Gibco 11965, 
Invitrogen Co.) with 10% v/v FBS (Gibco 10082, Invitrogen Co.), and 1% v/v antibiotic-
antimicotic (Gibco 15240, Invitrogen Co.).  All the c lls were cultured in a humidified 
incubator (37oC in an atomosphere of 5% CO2).  Cell suspensions for the hanging drop 
experiments were made by dissociating cells with 0.25% trypsin-EDTA (Gibco 25200, 
Invitrogen Co.), centrifugation of dissociated cells at 1000 rpm for 1 min at room 









On the spheroid culture plate, a 15 µl cell suspension was dispensed into the 
access hole at each cell culture site to form a hanging drop (Figure 3.1c).  In order to 
prevent evaporation, 4 ml of distilled water was added into the peripheral water reservoir.  
In addition, the plate was sandwiched by a well-plate id and a 96-well plate filled with 
distilled water, and wrapped using Parafilm (Figure 3.1e).  The growth media was 
exchanged every other day by taking 5 µl of solution from a drop, and adding 7 µl of 
fresh growth media into a drop to account for minor evaporation of the original drop.  For 
the osmolality measurement, 10 µl sample solution was pipetted out from a drop and 
transferred to a vapor pressure osmometer (Vapro Model 5520, Wescor Inc., Logan, UT) 
for analysis. 
 
3.2.4 Anti-Cancer Drug Sensitivity Testing 
 
For demonstration of anti-cancer drug sensitivity testing, A431.H9 spheroids at 
three different sizes (300, 1500, and 7500-cell spheroids) were tested under the effect of 
two types of drug—tirapazamine (TPZ) (Toronto Research Chemicals Inc., Ontario, 
Canada) and 5-fluorouracil (5-FU) (Sigma-Aldrich Co., St. Louis, MO).  According to 
the procedure mentioned above, A431.H9 spheroids at the specified cell numbers were 
formed, and their growth media were exchanged every other day.  TPZ and 5-FU stock 
solutions of four times the final testing concentrations (0, 0.1, 1, 10, 100, 1000, 5000 µM) 
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were initially prepared in Dulbecco’s phosphate buffered saline (D-PBS) (Gibco 14190, 
Invitrogen Co.).  On day 2 of A431.H9 spheroid culture, 5 µl of the appropriate 
concentration of TPZ (or 5-FU) stock solutions was subsequently added to each of the 15 
µl A431.H9 cell hanging drop droplets to generate 20 µl hanging drops of cells with 
drugs.  Cellular viability was monitored at 24, 48, 72, and 96 hours of drug incubation 
using alamarBlue (DAL1025, Invitrogen Co.).  Following manufacturer’s protocol, 2 µl
(one-tenth of each hanging drop sample volume) of alam rBlue was added to each 
A431.H9 hanging drop spheroid sample and incubated for 2 hours.  Following incubation, 
each A431.H9 hanging drop spheroid sample plate was read using a plate reader (FLx800 
Fluorescence Microplate Reader, BioTek Instruments I c., Winooski, VT) at 525 nm 
excitation and 590 nm emission to obtain fluorescence intensity readouts.  As the 
fluorescence intensity of alamarBlue is directly proportional to cell number (Figure 3.3c), 
the average percent cell viability for each drug concentration could be calculated by 
normalizing to the 0 µM untreated spheroid control.  The viability result achieved by the 
alamarBlue assay were also compared to the viability results obtained by fluorescence 
microscopy imaging using conventional live/dead stain (LIVE/DEAD 
Viability/Cytotoxicity Kit for mammalian cells, L324, Invitrogen Co.).  The detailed 
method of the comparison is shown in the following section with results highlighted in 
Figure 3.3.  Anti-cancer drug sensitivity experiments under 2D control conditions were 
performed in standard tissue culture treated 96-well plates (Corning Costar 3596, Corning 
Inc., Lowell, MA), with everything else being the same as the 3D spheroid experiments. 
 




In order to confirm the viability results achieved by the alamarBlue assay used in 
anti-cancer drug sensitivity testing (mentioned above), we compared the results to the 
viabilities obtained by fluorescence microscopy imaging using conventional live/dead 
stain.  A431.H9 spheroids (initially 1500 cells/spheroid) treated with 5-FU at various 
concentrations for 48 hrs were stained using LIVE/DA  Viability/Cytotoxicity Kit for 
mammalian cells (L3224, Invitrogen).  The kit measure  the cell viability based on the 
integrity of cell membranes.  The live cells are stained by calcein AM, which emit green 
fluorescence light (517 nm) when excited by blue light (494 nm); while the dead cells are 
stained by ethidium homodimer-1, which emit red fluorescence light (617 nm) when 
excited by green light (528 nm). 
 
To estimate the viabilities from the fluorescence images of 3D spheroids, we 
captured the fluorescence images at 10 different focal planes spaced 20 µm apart.  The 
images were then reconstructed by stacking focused parts of each figure into a single 
image using an image processing and analysis software ImageJ developed by NIH with a 
plug-in, Stack Focuser, which is developed by Michael Umorin 
(http://rsbweb.nih.gov/ij/plugins/stack-focuser.html).  The percentage of live (green) and 
dead (red) cells for each spheroid can subsequently be determined from the processed 
images and compared to the untreated control. 
 
Moreover, we tested the linearity of the alamarBlue assay for 3D spheroids 
viability measurements.  Uniformly sized 1500-cell A431.H9 spheroids were transferred 
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into 96-well plates at various numbers of spheroids per well, and performed alamarBlue 
assay (6 hr-incubation) for the wells with different spheroid numbers.  The linearity of 
the alamarBlue fluorescent intensity versus the number of spheroids per well was 
subsequently confirmed on a graph. 
 
 
3.3 Results and Discussion 
 
3.3.1 Formation of Hanging Drops for Spheroid Culture 
 
A schematic of the 384 hanging drop array plate is shown in Figure 3.1a and an 
actual picture of the plate containing 192 hanging drops arranged in an alternating 
fashion is shown in Figure 3.1b.  The hanging drop spheroid culture sites are arranged in 
the standardized 384-well plate format with 16 rows and 24 columns separated by 4.5 
mm apart in both directions.  A water reservoir designed in the outer ring of the plate 
further holds up to 4 ml of water to alleviate evaporation problem (Figure 3.1a, b, e).  The 
enlarged cartoon in Figure 3.1a further shows the access hole on the top surface of the 
plate with a liquid droplet hanging and confined by the diameter of the plateau on the 
bottom surface.  As a result, the geometry of the hanging drop can be kept consistent 
during the culturing process without spreading out,which leads to more robust and stable 
culturing conditions not possible on conventional fl t hanging drop substrates.  Figure 
3.1c illustrates the droplet and spheroid formation process in the 384 hanging drop array 
plate.  After a cell suspension droplet is successfully ormed, cells slowly aggregate in the 
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bottom center of the droplet and eventually form into spheroid.  The access holes allow 
direct manipulation of the droplets from the top, thus greatly simplifying the initial 
droplet formation and subsequent media exchange procedures by eliminating the tedious 
hanging drop culture dish inversion required in theconventional hanging drop method.  
Figure 3.1d is a snapshot of the hanging drop formation process in the 384 hanging drop 
array plate by a commercially available liquid handler (CyBi-Well, CyBio Inc.). 
 
3.3.2 Long-term Culture of Spheroids in Hanging Drops 
 
In order to culture spheroids over long periods of time, the osmolality of the cell 
culture media in the hanging drops must be kept stable.  Due to the small volume nature 
of the hanging drops, evaporation is inherently rapid nd can cause large osmolality shifts 
in the culture media.  In order to prevent this during spheroid culture, the 384 hanging 
drop array plate was sandwiched by a well-plate lid and a 96-well plate filled with 
distilled water, and the whole setup subsequently wrapped in parafilm (Figure 3.1e).  The 
water-filled 96-well plate directly on the bottom of the hanging drops provides significant 
humidification to the hanging drops.  In addition, the water reservoir (Figure 3.1a, b, e) in 
the periphery of the plate further prevents serious evaporation from the hanging drops 
near the edges of the plate where droplets are morepr ne to evaporation.  To investigate 
the long-term stability of the hanging drop spheroid cultures, osmolality measurements 
were performed.   Figure 3.2a shows a plot of the average osmolality of the COS7, mES, 
and A431.H9 cell culture media versus time over 7 to 12 days.  With exchange of 
approximately 30% of the culture media every other day, the osmolality of the media was 
 
 52 
kept in the optimal culture range of 300 to 360 mmol/kg (Ozturk and Palsson 1991; Zhou 
et al. 1997; Takagi et al. 2000).  Figure 3.2b shows the live/dead images of the COS7 and 
mES cell spheroids, indicating that most cells (>90%) were still alive after 12 days of 
culture.  Figure 3.2c shows that A431.H9 spheroids of various initial sizes are still 
proliferating over a 7-day culture period.  The ease of media exchange and stability of the 
drop geometry enabled by the inverted plateau structu es of the custom 384 drop plate 
allow for convenient long-term spheroid culture in ways not possible with the 
conventional hanging drop culture method. 
 
3.3.3 Viability Assays for 3D Spheroids 
 
Routine analysis of cell survival in 3D culture systems is often difficult due to 
various diffusion and transport limitations in the complex 3D cellular structures.  In order 
to confirm the viability results achieved by the alamarBlue assay used in anti-cancer drug 
sensitivity testing, we compared the results obtained from alamarBlue assay to the 
viabilities obtained by fluorescence microscopy imaging using conventional live/dead 
stain.  Figure 3.3a shows the comparison between th two methods, and Figure 3.3b 
shows the reconstructed fluorescence images.  For the four concentrations tested in the 
experiments, the viabilities obtained from the two methods have discrepancies less than 
10%, except for the 1 µM 5-FU case.  Such viability discrepancy may be caused by the 
different principles for estimating the cell viability in these two methods.  In addition, due 
to the 3D structures of the spheroids, it is usually challenging to image an intact spheroid.  




In addition to validating the alamarBlue assay by comparison with live/dead 
staining, the linearity of the alamarBlue assay for 3D spheroids viability measurements 
was also tested directly.  The alamarBlue fluorescence intensities for different amount of 
spheroids were measured on a plate reader after incubation.  Figure 3.3c shows the 
measurement results, which suggests the excellent linearity of the assay.  In summary, 
precisely estimating cell viability for 3D cultures in a high throughput manner is still a 
challenging task, and alamarBlue assay demonstrated in this chapter provides a 
reasonable solution to routine analysis of cell viability. 
 
3.3.4 Anti-cancer Drug Sensitivity Testing 
 
To analyze cell-based assay capability, an anti-cancer drug sensitivity test was 
performed using 2 drugs with distinctly different activity profiles: a conventional anti-
cancer drug 5-fluorouracil (5-FU, Sigma-Aldrich Co., St. Louis, MO) that inhibits 
cellular proliferation (Valeriote and Santelli 1984), and a hypoxia-triggered cytotoxin 
tirapazamine (TPZ, Toronto Research Chemicals Inc.,Ontario, Canada) that causes DNA 
damage (Peters et al. 2001), on A431.H9 cells under both 2D and 3D spheroid culture 
conditions.  Figure 3.4a shows cell viability at 10 µM 5-FU 96 hours after drug treatment 
for 7500-cell A431.H9 spheroids and 2D culture condition.  At the same 5-FU 
concentration, there is only 5% viability relative to untreated control for 2D cultures, but 
still 75% viability relative to control for 3D spheroids.  This clearly shows that A431.H9 
cells are more resistant to 5-FU in 3D than 2D cultures.  Figure 3.5a and b further show 
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that the IC50 of A431.H9 cells cultured in 2D condition is about 0.1 µM, while the IC50 of 
the A431.H9 3D spheroids is more resistant with an IC50 of 1 to 100 µM.  Due to the 3D 
integrity of spheroids, it is more difficult for 5-FU to diffuse and penetrate into the center 
cell mass.  Furthermore, 5-FU specifically targets proliferating cells, and thus would not 
kill the quiescent cells in the spheroids.  Whereas in 2D monolayer cultures, cells 
proliferate at a faster rate and thus 5-FU inhibits cellular growth more effectively. 
 
In contrast, TPZ is a hypoxia-activated cytotoxin.  Figure 3.4a shows that at 10 
µM TPZ 96 hours after drug treatment, there is still75% viability relative to control for 
2D cultures, but only 40% viability for 7500-cell A431.H9 spheroids.  The IC50 of 
A431.H9 cells cultured in 2D is about 50 µM, while the IC50 of the A431.H9 3D 
spheroids for all 3 sizes is about 8 µM (Figure 3.5c, d).  Here, A431.H9 cells are more 
resistant to TPZ when cultured under 2D rather than 3D conditions.  This is likely 
because TPZ is activated more in spheroids where active oxygen consumption by cells 
and limits in diffusive oxygen transport creates a hypoxic core similar to actual solid 
tumors (Sutherland 1988).  Such distinct cellular responses from the same cells to the 
same drugs tested under 2 different culture conditions highlights the importance of using 
3D models in drug screening and testing.  Statistical analysis ANOVA followed by 
pairwise comparisons between the culture conditions (spheroid sizes or 2D) using Holm-
Sidak tests were performed for each 5-FU and TPZ concentration groups.  The 




Finally, we performed combination drug treatment (5-FU and TPZ) on the 7500-
cell A431.H9 spheroids.  The combined treatment has an additive trend.  The viability is 
75% and 40% for spheroids treated with 10 µM of 5-FU and 10 µM of TPZ, respectively 
(Figure 3.4a).  But the viability decreased to only 20% when the spheroids were under 
combined treatment of 10 µM 5-FU and 10 µM TPZ (Figure 3.5e).  The additive effect is 
reasonable since 5-FU is an anti-proliferation drug that targets proliferating cells in the 
peripheral layers of spheroids and TPZ is a hypoxic drug that kills cells in the hypoxic 





We describe the design and fabrication of a high-throughput and versatile 384 
hanging drop array plate for cellular spheroid formation, culture, and drug testing.  The 
platform greatly simplifies the proven but traditionally inconvenient hanging drop 
culturing method in a format that is compatible with existing liquid handling robots.  
Anti-cancer drug sensitivity testing on A431.H9 cells show that cytotoxicity can be 
drastically different in the physiological 3D spheroids formed in the 384 hanging drop 
array plates compared to 2D monolayer cultures in co ventional multiwell plates.  
Although this study focused on response of cancer spheroids, the user-friendly high-
throughput 3D culture system is applicable to multiple cell types.  We believe the 
platform will be valuable in a wide range of studies where 3D spheroid cultures and high-




Figure 3.1.  (a) Illustration of the designed 384 hanging drop spheroid culture array plate, 
and its cross-sectional view.  (b) Photo and key dimensions of the array plate.  (c)
Cartoon of the hanging drop formation process in the array plate.  The pipette tip is first 
inserted through the access hole to the bottom surface of the plate, and cell suspension is 
subsequently dispensed.  Cell suspension is quickly attracted to the hydrophilic plate 
surface and a hanging drop is quickly formed and confined within the plateau.  Within 
hours, individual cells start to aggregate and eventually form into a single spheroid 
around 1 day.  (d) Photo of the 384 hanging drop array plate operated with liquid 
handling robot capable of simultaneously pipetting 96 cell culture sites.  (e) Cartoon of 
the final humidification chamber used to culture 3Dspheroids in the hanging drop array 
plate.  The 384 hanging drop array plate is sandwiched between a 96-well plate filled 
with distilled water and a standard-sized plate lid.  Distilled water from the bottom 96-
well plate and the peripheral water reservoir prevent serious evaporation of the small 
volume hanging drops. 
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Figure 3.2.  (a) Osmolality of the culture media from the hanging drops of COS7, mES, 
and A431.H9 cell spheroids with various cell populations over a 7- and 12-day culture 
period. Data are expressed as the mean ± s.e.m. (b) Fluorescence images of live/dead 
stained COS7 and mES cell spheroids over a 12-day culture. (c) Volume of A431.H9 
spheroids over a 7-day culture for various initial ce l numbers per spheroid.  n = 14 for 







Figure 3.3. (a) Comparison of cell viability of A431.H9 spheroids based on alamarBlue 
assay and fluorescence microscopy imaging with live/dead stain. (b) Fluorescence 
images of the A431.H9 spheroids treated with different concentrations of 5-Fu. (c) 
Alamar Blue assay linearity characterization: fluorescence intensity measurements in the 
Alamar Blue assay for different numbers of A431.H9 spheroids.  n = 5 for each 5-FU 
concentration in (a), and n = 5 for each spheroid number group in (c). Data are expressed 








Figure 3.4.  (a) Bar graph of the cell viability at 10 µM 5-FU, and 10 µM TPZ 96 hours 
after drug treatment for 2D A431.H9 monolayer culture and 7500-cell A431.H9 3D 
spheroid culture conditions.  For both drugs, the viability of A431.H9 cells was 
statistically different between 2D monolayer and 3D spheroid culture conditions.  
Statistical significance is determined by two-tailed Student’s t-Test (*, P < 0.01)  P = 
1.75 x 10-16 for 5-FU, P = 1.22 x 10-6 for TPZ.  n = 8 for 2D culture condition and n = 14 
for 3D spheroid culture condition.  Data are expressed as the mean ± s.e.m.  (b) Time-
lapse images of control untreated 7500-cell A431.H9 spheroid, and spheroids treated with 
10 µM 5-FU, 10 µM TPZ, and 10 µM 5-FU + 10 µM TPZ 96 hours after treatment.  Scale 




Figure 3.5.  (a) Bar graph of the cell viability at various 5-FU con entrations 96 hours 
after drug treatment for 300, 1500, and 7500-cell A431.H9 3D spheroids and 2D culture 
condition.  Different letters between culture conditions (spheroid size or 2D) within a 5-
FU concentration represent a significant difference between the spheroid sizes or 2D (a, b, 
c, d = p < 0.01).  (b) Time-lapse images of 7500-cell A431.H9 spheroids treated with 10 
µM 5-FU.  (c) Bar graph of the cell viability at various TPZ cone trations 96 hours after 
drug treatment for 300, 1500, and 7500-cell A431.H9 spheroids and 2D culture condition.  
Different letters between culture conditions (spheroid size or 2D) within a TPZ 
concentration represent a significant difference betwe n the spheroid sizes or 2D (a, b = p 
< 0.01).  (d) Time-lapse images of 7500-cell A431.H9 spheroids treated with 10 µM TPZ.  
(e) Bar graph of the cell viability at various 5-FU con entrations 96 hours after drug 
treatment for 7500-cell A431.H9 spheroids with 0, 1, 10, and 100 µM TPZ.  (f) Time-
lapse images of 7500-cell A431.H9 spheroids treated with 10 µM 5-FU + 10 µM TPZ.  
Statistical analysis was performed by ANOVA followed by Holm-Sidak tests.  Spheroid 
size or 2D groups that are statistically significantly different are designated with different 
letters (a, b, c, d).  n = 8 for 2D culture condition and n = 14 for 3D spheroid culture 
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384 Hanging Drop Array Plate Characterization, Modification, and 
Biomedical Applications 
 
The previous chapter describes the development of a simple, user-friendly, and 
versatile 384 hanging drop array plate for 3D spheroid culture and the importance of 
utilizing 3D cellular models in anti-cancer drug sen itivity testing.  While the 384 
hanging drop array plate allows for high-throughput capabilities and offers significant 
improvements over existing 3D spheroid culturing methods, various issues remain to be 
addressed to improve the usability and enable broader use of the plate for practical long-
term 3D spheroid culture.  In this chapter, we describe efforts to characterize the 
robustness of the 384 hanging drop array plate in trms of assay performance and long-
term stability of the hanging drops, and show the versatility of the plate.  We find that the 
original 384 hanging drop array plate performance is very robust in fluorescence- and 
colorimetric-based assays.  We subsequently moved on to modify the plate to further 
optimize for long-term stability of the hanging drops.  Finally, we demonstrate different 
plate capabilities and applications, including: spheroid transfer and retrieval for Janus 
spheroid formation and analysis, sequential addition of reagents or cells for sequential 
drug treatment and concentric layer patterning of different cell types, and culture of a 
wide variety of cell types.  Collectively, these results prove that the versatile and robust 
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384 hanging drop array plate for 3D spheroid culture is as practical and user-friendly as 





4.1.1 Need for High-throughput 3D Cell Assays 
 
High-throughput 3D cell culture is motivated by theneed to work with accurate in
vitro models in drug discovery and therapy test programs.  In vitro tumor models where 
cells are cultured outside living systems are central to the development of novel drugs 
and therapeutics.  However, typical in vitro models where cells are cultured in 
conventional 2D petri-dishes do not faithfully recapitulate the physiological 
environments in vivo.  Various cell types have been shown to behave diff rently when 
cultured under 2D vs. 3D (Yamada and Cukierman 2007).  With increasing realization 
that the surrounding environment is critical to cells, various 3D culture systems that 
better mimic physiological tissues have been valued as important research tools.  
Spheroids, which are spherical clusters of cells formed by self-assembly, stand out as one 
of the best models for 3D culture (Kunz-Schughart et al. 2004; Friedrich et al. 2009).  
Currently, however, most initial studies in drug development are still based on 2D cell 
assays, which often skew research results and have limit d predictive power in clinical 
efficacy (Hirschhaeuser et al. 2010).  Since the time and costs of drug development 
increase substantially during the animal models phase and even more in the subsequent 
clinical trials, it is crucial to identify promising candidates accurately in the early 
developmental stages.  Implementation of high-throughp t 3D cell culture screening 
assays is anticipated as a potent tool to expedite and accurately select key molecules in 
drug development.  Although the advantages of spheroids are widely known, it has been 
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difficult to scale up spheroid culture.  Typical spheroid culture methods are often tedious, 
low-throughput, difficult to handle, and produce non-uniform samples.  Various such 
complications have thus hindered more researchers from adapting the more accurate 3D 
spheroid cultures into routine use.  To promote wider usage of 3D spheroid cultures in 
research and pharmaceutical development, we have succe sfully developed the 384 
hanging drop array platform for high-throughput spheroid culture that offers simplified 
liquid handling procedures and compatibility with hig -throughput screening (HTS) 
instruments (such as plate readers and liquid handling robots) as mentioned in the last 
chapter. 
 
4.1.2 Z’-factor and Z-factor 
 
HTS is an essential initial step in drug discovery.  The ability to identify true 
active compounds (“hits”) depends greatly on the quality of assays and proper analysis of 
data (Zhang et al. 1999 Sui and Wu 2007).  Therefore, high-throughput 3D cell culture 
needs reliable assays for endpoint analysis to obtain accurate readouts.  Assays for HTS 
not only need to be miniaturized in sample volume, high-throughput, and robust, but also 
require adequate sensitivity, reproducibility, and accuracy in order to discriminate among 
a large pool of compounds that produce a huge range of activity (Zhang et al. 1999).  In 
most HTS experiments, because each compound is only tested in singlet or duplicate, a 
high degree of accuracy and sensitivity in the assay is critical for identifying hits (Zhang 
et al. 1999).  Since practically all assay methodologies contain instrumental and human-
associated errors and perturbations, all of the measur ments from an assay contain some 
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degree of variability.  Real hits need to be identified despite such signal measurement 
variation.  As a result, assessment of the screening data variability is critical in 
determining whether an assay can identify hits with confidence in the design and 
validation of HTS assays.  A high quality HTS assay must be able to identify the few 
compounds with desired biological activity with hig confidence.  Previously, signal-to-
noise ratios (S/N) and signal-to-background ratios (S/B) have been used to evaluate the 
performance of HTS assays (Sittampalam et al. 1997).  These concepts are constructive 
and useful; however, they still lack uniformity and simplicity in analysis of the relevant 
parameters.  Over the past decade, researchers from the HTS community have used the Z-
factor (Zhang et al. 1999) as a widely accepted standard to evaluate the quality of a HTS 
assay. 
 
Z’- or Z- factor is an assay performance measurement that provides an easy and 
useful summary of assay quality and robustness (Zhang et al. 1999; Sui and Wu 2007; 
Birmingham et al. 2009).  Z’-factor is typically used in assay optimization as it is based 
on controls, whereas Z-factor is often used during screening to assess performance of the 
screen on actual samples (Zhang et al. 1999; Birmingham et al. 2009).  Z’- and Z-factors 
are defined as follows (Zhang et al. 1999): 
Z’-factor = 1 – (3σhc + 3σlc) / │µhc – µlc│ 
Z-factor = 1 – (3σs + 3σc) / │µs – µc│ 
µ indicates mean, σ indicates standard deviation, “hc” indicates the high-value control 
(positive control), “lc” indicates the low-value control (negative control), “s” indicates 
sample value, and “c” indicates negative control.  The range of both measure is from 
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negative infinity to 1, with > 0.5 as a very good ass y, > 0 an acceptable assay, and < 0 
an unacceptable assay (Zhang et al. 1999; Birmingham et al. 2009).  Table 4.1 (Zhang et
al. 1999; Birmingham et al. 2009) summarizes the meaning of Z’- and Z-factors in more 
detail.  To characterize the performance of our 384hanging drop plate for fluorescence- 
and colorimetric-based assays, we utilized various concentrations of fluorescein and 
yellow food color liquid as sample drops to calculate the Z’- and Z-factors.  For both 
fluorescence-and colorimetric-based assays, we show that the Z’- and Z-factors 
calculated for the 384 hanging drop plate are comparable to those values obtained from 
commercially-available clear 384-well plates. 
 
4.1.3 Original Design of the 384 Hanging Drop Array Plate 
 
The current 384 hanging drop array plate (Figure 4.2a) as described in Chapter 3 
offers considerable advancements to the current 3D spheroid culture standards.  It not 
only offers high-throughput capability suitable forthe pharmaceutical industry, but is also 
designed in a simple, convenient multi-well plate format already familiar to researchers 
in academia.  Nevertheless, to further improve the usability and versatility of the plate to 
benefit more users and allow for a wider range of applications, the current plate must be 
optimized for stable long-term culture.  Specifically, the long-term stability of the 
droplets hanging from the access holes of the current plate must be addressed.  The 
original plate design is limited by the spontaneous spreading out of droplets over time, 
and its easy susceptibility to spread out upon sudden accelerations such as shocks and 
strikes.  Droplets formed in the original version of the plate have been found to be prone 
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to spreading out from the bottom of the plate in incubator cultures of more than 7 days 
(Figure 4.2b).  Unexpected collisions or other physical disturbances on the hanging drops 
further exacerbate the droplet instability issue and lead to coalesce of droplets.  In 
addition, during routine fluid manipulations, once w t pipette tips come in contact with 
the top flat surface of the plate (not directly inside the access holes), existing or 
subsequently formed droplets tend to merge with the undesired liquid remnant left on the 
top surface (Figure 4.2b).  These unwanted conditions altogether render the ruined 
hanging drops inappropriate for further spheroid culture and monitoring.  Therefore, there 
is a need to refine the current design of the 384 hanging drop plate to ensure that the 
hanging drops would be robust against sudden shocks and stable over time.  A recent 
publication by Kalinin et al. offers useful insights o enhance droplet stability using 
micro-topographical rings (Kalinin et al. 2008).  Here, we addressed these issues by 
modifying the original 384 hanging drop plate with the addition of extra micro-feature 
rings around the top surface access hole openings and the bottom surface plateaus (Figure 
4.2c, d).  We show that hanging drops formed in the newly modified plates are stable 
without the issue of droplets spreading out for up to 24 days of incubator culture. 
  
4.1.4 Techniques and Applications of Spheroid Cultures 
 
Many types of mammalian cells spontaneously aggregate into 3D spheroids when 
cultured in environments where cell-cell interactions dominate over cell-substrate 
interactions (Lin and Chang 2008; Hirschhaeuser et al. 2010; Friedrich et al. 2009).  
Recent realization of the importance of 3D cell culture has attracted more researchers to 
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adapt 3D spheroid cultures into biological studies.  Compared to conventional 2D 
monolayer cultures, 3D spheroids resemble physiological tissues and tumors much better 
in terms of structural and functional properties (Lin and Chang 2008).  Various primary 
or progenitor-like cell types also show significantly enhanced viability and functions 
when grown as spheroids (Lin and Chang 2008).  Recently, spheroid research has been 
devoted to various areas in biology including cancer biology, developmental biology, 
tissue engineering, and other disciplines.  Specifically, spheroids serve as excellent 
models for solid tumors, components in bioartificial livers (Lin and Chang 2008), cellular 
building blocks in tissue engineering, and embryoid bodies.  Tumor spheroids can be 
used to study various types of cancers that are found growing as spherical aggregates in 
vivo, such as the ascites in ovarian cancer (Shield et al. 2009).  They have also been used 
widely as models to study cancer stem cells, cancer m tastasis, invasion, and for 
therapeutic screening (Lin and Chang 2008; Hirschhaeuser et al. 2010).   In addition, 
spheroids can also be applied to study cellular migration and tumor dissemination from 
3D constructs, signaling and cross-talks between cells cultured in 3D environments 
(secreted autocrine and paracrine factors from 3D constructs with inherent metabolic 
profiles and diffusion/transport limitations), 3D cell-cell interactions and confrontational 
studies, differentiation of stem cells from co-cultures of different cell types or addition of 
factors, and 3D patterning for tissue engineering purposes.  However, many of these 
studies require sophisticated manipulation and analysis techniques not commonly 
attainable through conventional spheroid formation platforms, such as formation of 
uniform pool of spheroids, formation of multi-cell type mixed co-culture spheroids, 
sequential addition of reagents, and retrieval and d ition of single cell suspensions or 
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spheroids.  Here, we demonstrate the versatility of our plate with biomedical applications 
in the formation of a wide variety of spheroids from different cell types, concentric layer 
patterning of different cell types into spheroids, mixed co-culture spheroid formation, and 
spheroid transfer for 3D cell confrontations. 
 
 
4.2 Materials and Methods 
 
4.2.1 Z’-factor and Z-factor Calculations 
 
To calculate the Z’-factor and Z-factor of the 384 hanging drop array plate for 
fluorescence- and colorimetric-based assays, we formed 15 µl hanging drops in all 384 
sites of the plate from various concentrations of fluorescein (sodium salt, F6377, Sigma-
Aldrich Co.) and yellow food color, respectively, according to the concentration maps 
shown in Figure 4.1a, c. 
 
For fluorescence-based assay, 1mg/mL stock solution of fluorescein was first 
prepared and dissolved in PBS (Phosphate-Buffered Saline, Gibco 10010, Invitrogen Co.).  
The stock solution was subsequently serially diluted to all the concentrations listed in the 
map (Figure 4.1a, range from PBS only—negative control to 50µg/mL—positive control).  
384 15 µl hanging drops were then formed in the 384 hanging drop plate from all the 
concentrations of fluorescein solutions using a robotic liquid handler (CyBi-Well, CyBio 
Inc.).  The plate was then read on a microplate reader (PHERAStar FS, BMG Labtech), 
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with 485 nm excitation, 520 nm emission and reading from the bottom of the plate to 
obtain fluorescence intensity readouts.   Z’-factor and Z-factors at each fluorescein 
concentration was then calculated from the fluorescence intensity readings according to 
the formulas mentioned above. 
 
For colorimetric-based assay, 100% solution of yellow food color was first 
prepared by adding 175 µL of stock yellow food color (McCormick & Company, Inc.) 
into 100 mL of distilled water (Gibco 15230, Invitrogen Co.).  A percentage dilution, 
beginning with the 100% solution of yellow food color, was then performed to make all 
the percentages listed in the map (Figure 4.1c, range from distilled water only—negative 
control to 100% yellow food color solution—positive control).  384 15 µl hanging drops 
were then formed in the 384 hanging drop plate from all the percentages of yellow food 
color solutions using a robotic liquid handler (CyBi-Well, CyBio Inc.).  The plate was 
then read on a microplate reader (PHERAStar FS, BMG Labtech) to determine the 
absorbance of each yellow food color percentage at 405nm.  Z’-factor and Z-factors at 
each yellow food color percentage was then calculated from the absorbance readouts 
according to the formulas mentioned above. 
 
The same fluorescein and yellow food color solutions were also pipetted into 
standard clear, polystyrene 384-well plates (Corning COSTAR 3701) at 2 volumes (15 µl 
and 50 µl) using a robotic liquid handler (CyBi-Well, CyBio Inc.) in the same 
concentration pattern as the 384 hanging drop plates (Figure 4.1a, c).  The plates were 
subsequently read on a microplate reader (PHERAStar FS, BMG Labtech) using the 
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same settings as for the 384 hanging drop plates to ob ain fluorescence intensity and 
absorbance readouts.  Z’-factor and Z-factors at each yellow food color percentage was 
then calculated from the fluorescence intensity and bsorbance readouts according to the 
formulas mentioned above for comparison with the data from the 384 hanging drop plates. 
 
4.2.2 Modifications to the Original 384 Hanging Drop Array Plate 
 
To enhance the long-term stability of the hanging drops in the 384 hanging drop 
plates, extra micro-topographical ring-like structures were proposed to be added to the 
bottom surface of the plate around the plateaus (Figure 4.2d).  In addition to the original 
bottom plateau design of the plate, a bottom trench design was also considered (Figure 
4.2d).  The proposed extra bottom ring structure would subsequently be added to either 
the original bottom 0.5 mm height plateau design or the new 0.5 mm deep trench design 
(Figure 4.2d), depending on droplet stability test results.  In order to determine the best 
ring dimensions to enhance droplet stability, varying dimensions of the extra bottom ring 
structures (Table 4.2) were compared.  Rapid prototype plates each with multiple 
different design features and dimensions (Table 4.2) were fabricated by a 
stereolithography machine (SLA Viper si2, 3D Systems, Inc.).  A piece of glass slide was 
attached to the bottom of each prototype plate (Figure 4.3a).  15 µL cell culture media 
(GIBCO 11965 DMEM + 10% FBS (number) + 1% Anti-Anti (number)) droplets were 
formed in 2 hanging drop sites located at 2 different radii (R1 and R2) for each design.  
The rapid prototype plates were each subsequently placed on a spin coater (Cee 200X, 
Brewer Science, Inc., Rolla, MO) and spun at increasing speeds (with 4 seconds of ramp 
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time and 20 seconds of total spin time), starting at 210 rpm with 30rpm increments until 
the media droplets spread out.  The maximum speed at which each of the droplets spread 
out was recorded and characterized for droplet stability design characterization.  The 
rationale is that depending on the distance (R1 or R2) of the droplets to the center of the 
spindle, each droplet will experience different centripetal acceleration.  The best design is 
determined to be the one that is able to maintain the droplet stable at the highest 
centripetal acceleration.  The centripetal acceleration is calculated using the following 
formula: 
ac = v
2/r = (ωr)2/r = ω2r 
ac is the centripetal acceleration, v is the linear velocity, r is the radius, ω is the angular 
velocity. 
 
To prevent droplets from merging with undesired liquid remnants unintentionally 
left on the top surface of the plate, both extra micro-topographical ring-like and trench-
like structures were proposed to be added to the top surface of the plate around the 
openings of the access holes.  Four different dimensions were compared for the extra ring 
and trench designs (Table 4.3).  A rapid prototype plate with a total of 8 design features 
and dimensions (Table 4.3) was fabricated by a stereolithography machine (SLA Viper 
si2, 3D Systems, Inc.).  15 µL cell culture media (Gibco 11965 DMEM + 10% FBS 
(number) + 1% Anti-Anti (number)) droplets were formed by manually pipetting in 192 
access holes at staggered positions.  The plate was subsequently sandwiched between a 
96-well plate lid and plate filled with distilled water, and incubated in a humidified 
incubator (37oC in an atomosphere of 5% CO2) for a total of 8 days.  Cell culture media 
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was exchanged every other day using a multi-channel pip ttor (remove 5 µL out and add 
back 7 µL in), and the number of droplets spreading out on he top surface of the plate 
was recorded for each design.  The best design was determined to be the one with the 
least number of droplets spreading out from the top surface. 
 
4.2.3 Testing the Stability and Robustness of Hanging Drops in the Modified 384 
Hanging Drop Array Plate 
 
 
Unfortunately, due to the original injection mold manufacturing limitations 
(Xcentric Mold & Engineering, Inc., Chesterfield, MI), the desired design cannot be 
fabricated precisely as the proposed ring features w re too small (both top and bottom 
rings with 0.25 mm width and 0.50 mm height) (Figure 4.2e).  Therefore, the final design 
was compromised to ring features with 0.5 mm width and 0.50 mm height (Figure 4.2e).  
The new refined plates were also fabricated by injection molding in the same clear 
polystyrene material as the original plates.   
 
To compare the hanging drop stability in both the original and new design plates, 
384 15µL hanging drops were formed in both the original and new plates by a liquid 
handling robot (CyBi-Well, CyBio Inc.).  The plates were not coated in 0.1% Pluronic 
F108 (BASF Co., Ludwigshafen, Germany) solution as de cribed in Chapter 3, but 
directly UV sterilized in a UV oven chamber for 30 minutes prior to use.  After forming 
handing drops, the plates were sandwiched between a 96-well plate lid and plate filled 
with distilled water, and incubated in a humidified incubator (37oC in an atomosphere of 
5% CO2) for 14 days.  Cell culture media was exchanged every other day using the liquid 
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handling robot (remove 5 µL out and add back 7 µL in).  Right after media exchange, 
each plate was then placed through 20 cycles of up and down, left and right motions on 
the liquid handling robot stage at the maximum speeds allowed by the liquid handler 
settings.  The number of droplets spreading out from b th the top and bottom surfaces of 
the plate was recorded for each plate after the cycles. 
 
4.2.4 General Cell Culture 
 
Murine embryonic stem (mES) cells (ES-D3) cells were cultured in dishes coated 
with 0.1% w/v porcine gel (Sigma-Aldrich Co.) and maintained in medium consisting of 
Dulbecco’s Modified Eagle’s Medium (DMEM) (Gibco 11960, Invitrogen Co., Carlsbad, 
CA) with 15% v/v fetal bovine serum (FBS) (Gibco 10082, Invitrogen Co.), 4 mM L-
glutamin (Invitrogen Co.), 0.1mM 2-mercapto-ethanol (Sigma-Aldrich Co.), 0.02% v/v 
sodium pyruvate (Sigma-Aldrich Co.), 100 U/ml penicillin (Invitrogen Co.), 100 U/ml 
streptomycin (Invitrogen Co.), and 1000 U/ml ESGRO (Invitrgoen Co.) which contains 
leukemia inhibitory factor (LIF).  HepG2 hepatocellular carcinoma cell line was cultured 
in DMEM (Gibco 11965, Invitrogen Co.) with 10% v/v FBS (Gibco 10082, Invitrogen 
Co.), and 1% v/v antibiotic-antimicotic (Gibco 15240, Invitrogen Co.).  DU145 and PC-
3DsRed prostate cancer cell were cultured in RPMI-1640 (Gibco 61870, Invitrogen Co.) 
with 10% v/v FBS (Gibco 10082, Invitrogen Co.), and 1% v/v antibiotic-antimicotic 
(Gibco 15240, Invitrogen Co.).  HFOB human fetal oste blasts were cultured in D-
MEM/F-12 (Gibco 10565, Invitrogen Co.) with 10% v/v FBS (Gibco 10082, Invitrogen 
Co.), and 1% v/v antibiotic-antimicotic (Gibco 15240, Invitrogen Co.).  MC3T3-E1 
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murine pre-osteoblasts were cultured in α-MEM (Alpha Minimum Essential Medium; 
Gibco A10490, Invitrogen Co.) supplemented with 15% (v/v) FBS (Gibco 10082, 
Invitrogen Co.), and 1% v/v antibiotic-antimicotic (Gibco 15240, Invitrogen Co.).  
Differentiation of MC3T3-E1 cells into osteoblasts was only induced when cultured as 
spheroids by addition of 50 µg/ml ascorbic acid.  HUVEC human umbilical vein 
endothelial cells (Lonza) passage number 2-6 were cultured in endothelial growth 
medium-2 (EGM-2, Lonza).  All the cells were cultured in a humidified incubator (37oC 
in an atomosphere of 5% CO2).  Cell suspensions for the hanging drop experiments were 
made by dissociating cells with 0.25% trypsin-EDTA (Gibco 25200, Invitrogen Co.), 
centrifugation of dissociated cells at 1000 rpm for 5 minutes at room temperature, and re-
suspended in growth media.  Cell density was estimated using a hemocytometer. 
 
4.2.5 Spheroid Formation, Co-culture Spheroid Formation, Concentric Layer 
Patterning, and Spheroid Transfer in the 384 Hanging Drop Array Plate 
 
 
General mono-culture spheroid formation was performed as previously described 
in Chapter 3.  Mixed co-culture spheroids were generated by first preparing mixed cell 
suspensions from the desired cell types at the specified ratios followed by the same 
hanging drop formation protocol for mono-culture spheroids.  Concentric layer patterning 
of different cell types within a spheroid was achieved by initially forming a mono-culture 
spheroid of one cell type as the inner core.  After one day, once the initial cell type 
aggregates, the single cell suspension of the second ell type was subsequently added to 
the existing hanging drop to form an exterior coating around the inner core.  Spheroid 
transfer within the hanging drop plate for Janus spheroid (Torisawa et al. 2009) formation 
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or 3D cellular confrontation was achieved by direct pipetting to retrieve spheroid from 
the top of an access hole and then gently pipette in o another existing hanging drop 
containing spheroid just like the removal and addition of liquid.  Such spheroid 
transferring process was demonstrated by both manual pipetting and a liquid handling 
robot (CyBi-Well, CyBio Inc.). 
 
 
4.3 Results and Discussion 
 
4.3.1 Z’-factor and Z-factor of the 384 Hanging Drop Array Plate 
 
 Since one of the best applications of the 384 hanging drop plate is HTS for drug 
screening purposes, it is important to know the quality of various assays performed in the 
hanging drop plate.  We adapted the calculation of Z’- and Z-factors as assay 
performance measures to validate the robustness of fluorescence- and colorimetric-based 
assays in the 384 hanging drop plate.  Figure 4.1b and d summarize the Z’- and Z-factor 
calculations and comparisons for both the 384 hanging drop plate and the standard clear 
384-well plate.   
 
For fluorescence-based assays, Z-factors are all well-above 0.5 at all the 
fluorescein concentrations tested in the 384 hanging drop plate.  This indicates that the 
fluorescence-based assays performed in the 384 hanging drop plate are excellent within 
the range of concentrations tested (Table 4.1).  In addition, the Z-factors for the 384 
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hanging drop plate are all better or comparable to the Z-factors for the commercially 
available, standard, clear 384-well plate.  The Z-factors are anticipated to be even better 
if the 384 hanging drop plates are made of solid black polystyrene with solid walls 
around each hanging drop access hole to segregate each drop.  Typical fluorescence-
based assays are performed in solid black polystyrene multi-well plates as the black walls 
can reduce well-to-well crosstalk and background for fluorescent assay.  Nevertheless, 
the ability to conduct microscopy imaging would be compromised if the 384-well plates 
are made of solid black material.  Various design co siderations and complications must 
be carefully reviewed before making such a step. 
 
 For colorimetric-based assays, with the exception of the lowest two yellow food 
color percentages, all the other percentages have Z-factors above 0.5 in the 384 hanging 
drop plate.  This indicates that the colorimetric-based assays performed in the 384 
hanging drop plate are excellent within the 30% to 100% yellow food color solutions 
tested (Table 4.1).  The plate reader might not be sensitive enough to read the absorbance 
at 10% and 20% yellow food color.  As a result, a huge variation is generated in these 
low-value readouts, leading to low and even negative Z-factors.  Caution must be used 
when performing colorimetric-assays in the plates involving such low absorbance values.  
Nevertheless, the Z-factors for the 384 hanging drop plate are still comparable to the Z-
factors for the standard, clear 384-well plate at most yellow food color percentages tested.   
 
 It should also be noted that because the detection sensitivity, amount of cross-talk, 
and positional effects reflected in the plate reader readouts greatly depends on the make 
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and model of the microplate readers, the calculated Z’- and Z-factors will also change 
depending on the specific microplate reader used.  One should be consistent (and careful 
in choosing) in plate reader usage throughout the entire experiment from the initial 
evaluation of the robustness of the assays (Z’- and Z-factor calculations) to performing 
the actual assays in HTS. 
 
4.3.2 Droplet Stability in the Modified 384 Hanging Drop Array Plate 
 
In order to culture spheroids over long periods of time, the hanging drops in the 
384 hanging drop array plate must be kept stable over extended periods and should be 
robust against sudden perturbations.  In the original 384 hanging drop array plate, 
hanging drops tend to spread out over time and drops tend to spread out upon 
experiencing disturbing sharp accelerations due to abrupt impulses.  Once a droplet 
spreads out, the droplet becomes much more vulnerable to coalesce with neighboring 
drops.  Recent works by Kalinin et al. (2008) showed that micro-topographical ring 
structures greatly enhance the stability of droplets without spreading out.  Therefore, we 
tested the ability of different ring features added around existing bottom plateaus or the 
new trench designs (Table 4.2) to resist droplet spreading due to centripetal acceleration.  
Figure 4.3b summarizes the result.  A bottom trench design with extra ring feature of 0.25 
mm width and 0.50 mm height (Table 4.2, Design 20) was able to sustain the highest 
centripetal acceleration without droplet spreading out.  It is interesting to note that a 
bottom trench design alone without a ring feature (Table 4.2, Design 11) is the worst in 
terms of preventing droplets from spreading out (Figure 4.3b).  However, with the 
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addition of a ring structure around the trench (Designs 12 to 20), the stability of the 
hanging drops were greatly enhanced.  Without the ring structure, droplets inside the 
trench easily spread out to the neighboring bottom surface of the plate.  Whereas the ring 
structures provides a physical wall around the hanging drops to keep them stable.  The 
combination of a trench design and ring structure frther physically allows for a bigger 
volume of liquid to be held in the hanging drop and remain stable in place (as compared 
to the plateau design). 
 
To prevent droplets from spreading out on the top surface of the plate, extra ring 
(extrusion) and trench (dent) design modifications around the top surface of the access 
holes were tested against droplet spreading out.  Upon routine cell culture media 
exchange over the 8 days of incubation, some droplets will merge with undesired liquid 
remnants left by the pipette tips during media pipett ng.  Figure 4.3c shows the initial and 
final images of the actual test prototype plate.  It is clear that the extra ring design out 
performs the trench design with no droplets spreading out on the top surface while the 
trench design has several droplets spreading out since initial droplet formation on Day 0.  
It is also intuitive that since there is no physical b rrier around the trench designs, liquid 
tends to merge easily with remnants on the neighboring top surface once the surface 
becomes hydrophilic with the wetting of the pipette tips.  While the extra ring design 
contrasts with the trench design by providing a wall to guide pipette tips directly into the 
access holes and preventing the hanging drop from merging with liquid remnants on the 
top surface.   No significant difference was found between the different top ring 
dimensions.  As the modified design parameters were finalized, the original plate mold 
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was refined to add additional ring structures to the top and bottom surfaces of the plate.  
However, due to the mold manufacture limitations, the final ring dimensions have to be 
compromised to 0.5 mm width and 0.5 mm height for both the top and the bottom in the 
original plateau structure (Figure 4.2e).  It should also be noted that because the material 
used in the rapid prototypes is different from the cl ar polystyrene material used in the 
actual 384 hanging drop plates, the surface properties might be slightly different.  This 
could lead to minor differences in the test results from the rapid prototypes and the actual 
plate. 
 
The modified plate design with the added top and bottom ring features was 
manufactured by injection molding using the same clear polystyrene material as the 
original plates.  The original plate was compared to the modified plate for droplet 
stability during routine cell culture and media exchange procedures.  Figure 4.3d shows a 
summary of the number of droplets spread out in each plate over 14 days.  The modified 
plate performs exceedingly better than the original pl te in preventing droplets from 
spreading out.  The modified plate has no droplets spreading out over the 14 days of 
culture, while the original plate already has 7 droplets spreading out from the top surface 
during initial hanging drop formation on Day 0.  This demonstrates that the modified new 
plates are significantly enhanced in preventing droplets from spreading out in both the 
top and bottom surfaces.  It is also interesting to note that between Day 6 and Day 8, 
there is a sharp increase in the number of droplets that have spread out in the original 
plate.  This is most likely due to the coalescing of droplets leading to a chain effect.  
Because the 384 hanging drops are so closely spaced tog ther, once a droplet spreads out, 
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it becomes very vulnerable to merge with neighboring drops, creating a larger droplet that 
is even more unstable.  The modified plate with the extra ring structure around the bottom 
plateaus greatly prevents the initial drop from spreading out, thus enhancing the overall 
stability of the plate.  The modified plate was subsequently shown to be stable with no 
droplets spreading out until Day 24 when 33 drops spread out.  Additional four modified 
plates were also used in actual 3D spheroid culture experiments and were shown to be 
stable with no droplets spreading out throughout the extent of the 14-day experiment.  In 
addition to enhancing droplet stability, each access hole in the modified plates also holds 
more liquid due to the extra volume generated from the extra top ring.  This allows for 
bigger droplets to be more robust against physical perturbations, evaporation, and media 
osmolality shifts. 
 
4.3.3 Biomedical Applications of the 384 Hanging Drop Array Plate 
 
To allow more researchers to adapt the 384 hanging drop array plate for 3D 
spheroid culture, the platform must be versatile and pplicable to a wide variety of 
studies.  Here, we demonstrate several useful techniques made possible by the 384 
hanging drop plate that would otherwise be difficult to perform utilizing other spheroid 
formation and culturing methods.  We first demonstrate that 384 hanging drop array plate 
can be used to generate uniform mono-culture spheroids at various defined sizes from 
mouse embryonic stem (mES) cells (Figure 4.4a), HepG2 cells (Figure 4.4b), DU145 
prostate cancer cells (Figure 4.5a), and HFOB human fetal osteoblasts (Figure 4.5b).   
Uniform pool of spheroids and spheroid sizes are controlled by introducing defined 
 
 86 
numbers of cells to each hanging drop.  Such uniformity control feature is often very 
tedious or not possible in conventional spheroid formation methods.  Emerging micro-
technologies for spheroid formation (Fukuda et al. 2006; Lee et al. 2010; Sakai and 
Nakazawa 2007; Toh et al. 2007; Torisawa et al. 2007; Ungrin et al. 2008; Wu et al. 
2008) generally offer considerable improvements for spheroid uniformity control, but 
such custom-made delicate devices are often tedious to fabricate and requires specialized 
trainings to operate, and thus not readily available to the research community.  The 384 
hanging drop plate delivers the same advantage in a user-friendly manner. 
 
Next, we show the ability of the hanging drop plate to form mixed co-culture 
spheroids with randomly-distributed cell types.  Figure 4.6a shows the image of a mixed 
co-culture spheroid containing PC-3DsRed, HUVEC, and MC3T3-E1 cell at 1:50:50 ratio.  
Formation of co-culture spheroids using conventional rotating bioreactors, non-adherent 
surfaces, or even sophisticated micro-wells does not e sure uniform incorporation of all 
co-culture cell types into the spheroids.  Many times multiple types of spheroids 
comprised primarily of just one of the co-culture cell types rather than mixed co-culture 
spheroids were formed.  The hanging drop method overc mes this issue by forcing all 
cell types to aggregate into single spheroid by gravity, making formation of mixed co-
culture spheroids as simple as mono-culture spheroids.  In addition, co-culture spheroids 
can also be patterned in concentric layers.  Figure 4.6b demonstrates a PC-3DsRed and 
MC3T3-E1 co-culture spheroid at 1:100 ratio with PC-3DsRed cells preferentially 
patterned in the center core of the spheroid, as the exterior outside coating of the spheroid, 
or randomly distributed within the spheroid.  Such concentric patterning of spheroids can 
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easily be manipulated using the 384 hanging drop plate by varying the timing and order 
of seeding the different cell type suspensions into the hanging drops. 
 
Finally, we demonstrate that spheroids cultured in the 384 hanging drop plates 
can be easily retrieved and transferred to another existing hanging drop (Figure 4.6c).  
Figure 4.6d shows the before and after images of a green MC3T3-E1 spheroid being 
transferred to a red MC3T3-E1 spheroid.  This process can be easily performed on the 
hanging drop plate by simple manual pipetting or pipett ng by a robotic liquid handler 
from the top side of the plate.  Such technique is useful in 3D confrontational studies or 
formation of Janus spheroids (given enough time for the two spheroids to merge) where 
cell-cell-interactions in 3D can be studied.  In addition, spheroid transfer allows for 3D 
side-by-side patterning for tissue engineering purposes as well as differentiation studies 
of embryoid bodies co-cultured next to a second cell type.  Furthermore, since spheroid 
retrieval from the plate is such a simple process, specific spheroids can also be harvested 
for subsequent analysis by histology, flow cytometry, Q-PCR, Western blot, and other 





We describe the characterization, improvements, andversatility of the 384 
hanging drop array plate for HTS, long-term culture, and biomedical studies.  The 3D 
spheroid culture platform offers excellent and robust assay performance required by HTS 
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in drug discovery and therapeutic development industries.  The modified plate allows for 
extended long-term 3D spheroid culture in stable hanging drops.  The 384 hanging drop 
plate is also compatible with a wide variety of cell types.  Special spheroid manipulation 
techniques enabled by the platform to create different types of co-culture spheroids open 
up novel ways to study cancer biology, developmental biology, and tissue engineering in 
3D.  We believe the high-throughput hanging drop platform will be a valuable tool 
capable of revolutionizing current 3D cell culture standards in a wide range of disciplines. 
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Figure 4.1.  (a) Concentration map in 384-format plate for fluorescein solution.  (b) Bar 
graph showing the summary of Z-factors for fluorescence-based assay at various 
fluorescein concentrations.   (c) Concentration map 384-format plate for yellow food 
color solution.  (d)  Bar graph showing the summary of Z-factors for colorimetric-based 








Figure 4.2.  (a) Cartoon of the original 384 hanging drop array plate nd its cross-
sectional view with a hanging drop schematic drawing.  (b) Illustration of a cross-
sectional view of a hanging drop in an access hole of the 384 hanging drop plate and how 
the droplet spreads out from the top and bottom surfaces of the plate over time.  (c) 
Cartoon showing the cross-sectional views of the proposed modifications to the top 
surface of the plate—an extra ring structure or a trench structure around the access hole.  
(d) Cartoon showing the cross-sectional views of the proposed modifications to the 
bottom surface of the plate—an extra ring structure o the existing plateau, a new trench 
structure, or a new trench with an extra ring structure.  (e) Cross-sectional schematics of 
the original design, the optimized design, and the final modified design of a hanging drop 




Figure 4.3.  (a) Schematic of how the 384 hanging drop array prototype plates are tested 
on the spin coater with a glass slide attached to the underside of the plate to achieve a flat 
surface.  Representative hanging drops and their corresponding radii to the center of the 
spindle are also illustrated.  (b) Bar graph summarizing the maximum centripetal force a 
hanging drop could withstand before spreading out under different plate designs.  (c) Day 
0 and Day 8 (final day) photos of the top surface of the 384 hanging drop array prototype 
plate with different dimensions of the extra ring and trench designs.  The enlarged Day 8 
photo highlights droplets spreading out in the trench designs but not the ring designs.  (d) 
Graph of cell culture media hanging drops spreading out condition in the original and the 








Figure 4.4.  (a) Time-lapse images of mES-Oct4-GFP cell embryoid boies cultured in 
the 384 hanging drop array plate at two initial seeding densities.  (b) Time-lapse images 
of HepG2 cell spheroids cultured in the 384 hanging drop array plate at two initial 




Figure 4.5.  (a) Time-lapse images of DU145Luc prostate cancer spheroids cultured in the 
384 hanging drop array plate at three initial seeding densities.  (b) Time-lapse images of 
HFOB spheroids cultured in the 384 hanging drop array plate at three initial seeding 
densities.  Scale bare is 200 µm. 
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Figure 4.6.  (a) Phase and fluorescent images of a PC-3DsRed, HUVEC, MC3T3-E1 
(1:50:50 ratio) mixed co-culture spheroid.  (b) Images of PC-3DsRed and MC3T3-E1 
(1:100 ratio) co-culture spheroids with PC-3DsRed cells preferentially patterned in the 
center, exterior, or randomly distributed.  (c)  Cartoon illustrating the process of spheroid 
transfer between hanging drops in the 384 hanging drop array plate.  (d) Actual images of 
CellTracker Red- and Green-labeled MC3T3-E1 spheroids before and after transfer 












Table 4.2.  List of the specific dimensions of the different bottom surface structure 




Table 4.3.  List of the specific dimensions of the different top surface structure designs in 






1. Birmingham A, Selfors LM, Forster T, Wrobel D, Kennedy CJ, Shanks E, et al. 
Statistical methods for analysis of high-throughput RNA interference screens. Nat 
Methods 2009;6(8):569-75. 
 
2. Friedrich J, Seidel C, Ebner R, Kunz-Schughart LA. Spheroid-based drug screen: 
considerations and practical approach. Nat Protoc 2009;4(3):309-24. 
 
3. Fukuda J, Khademhosseini A, Yeo Y, Yang X, Yeh J, Eng G, et al. Micromolding 
of photocrosslinkable chitosan hydrogel for spheroid microarray and co-cultures. 
Biomaterials 2006;27(30):5259-67. 
 
4. Hirschhaeuser F, Menne H, Dittfeld C, West J, Mueller-Klieser W, Kunz-Schughart 
LA. Multicellular tumor spheroids: an underestimated tool is catching up again. J 
Biotechnol 2010;148(1):3-15. 
 
5. Kalinin Y, Berejnov V, Thorne RE. Controlling microdrop shape and position for 
biotechnology using micropatterned rings. Microfluid Nanofluidics 2008;5(4):449-
54. 
 
6. Kunz-Schughart LA, Freyer JP, Hofstaedter F, Ebner R. The use of 3-D cultures for 
high-throughput screening: the multicellular spheroid model. J Biomol Screen 
2004;9(4):273-85. 
 
7. Lee WG, Ortmann D, Hancock MJ, Bae H, Khademhosseini A. A hollow sphere 
soft lithography approach for long-term hanging drop methods. Tissue Eng Part C 
Methods 2010;16(2):249-59. 
 
8. Lin RZ, Chang HY. Recent advances in three-dimensional multicellular spheroid 
culture for biomedical research. Biotechnol J 2008;3(9-10):1172-84. 
 
9. Sakai Y, Nakazawa K. Technique for the control of spheroid diameter using 
microfabricated chips. Acta Biomater 2007;3(6):1033-40. 
 
10. Shields K, Ackland ML, Ahmed N, Rice GE. Multicellular spheroids in ovarian 
cancer metastases: Biology and pathology. Gynecol Oncol 2009;113(1):143-8. 
 
11. Sittampalam GS, Iversen PW, Boadt JA, Kahl SD, Bright S, Zock JM, et al. Design 
of signal windows in high throughput screening assay  for drug discovery. J Biomol 
Screen 1997;2(72):159-69. 
 
12. Sui Y, Wu Z. Alternative statistical parameter for high-throughput screening assay 




13. Toh YC, Zhang C, Zhang, J, Khong YM, Chang S, Samper VD, et al. A novel 3D 
mammalian cell perfusion-culture system in microfluidic channels. Lab Chip 
2007;7(3):302-9. 
 
14. Torisawa Y, Chueh BH, Huh D, Ramamurthy P, Roth TM, Barald KF, et al. 
Efficient synchronous formation of uniform-sized embryoid bodies using a 
compartmentalized microchannel device. Lab Chip 2007;7(6):770-6. 
 
15. Torisawa Y, Mosadegh B, Luker GD, Morell M, O’Shea KS, Takayama S. 
Microfluidic hydrodynamic cellular patterning for systematic formation of co-
culture spheroids. Integr Biol 2009;1(11-12):649-54. 
 
16. Ungrin MD, Joshi C, Nica A, Bauwens C, Zandstra PW. Reproducible, ultra high-
throughput formation of multicellular organization from single cell suspension-
derived human embryonic stem cell aggregates. PLoS ONE 2008;3(2):e1565. 
 
17. Wu LY, DiCarlo D, Lee LP. Microfluidic self-assembly of tumor spheroids for 
anticancer drug discovery. Biomed Microdev 2008;10(2):197-202. 
 
18. Yamada KM, Cukierman E. Modeling tissue morphogenesis and cancer in 3D. Cell 
2007;130(4):601-10. 
 
19. Zhang JH, Chung TD, Oldenburg KR. A simple statistical parameter for use in 





Elucidating the Biology of CD133+ Prostate Cancer Cells and Its 
Relationship to Tumor Dormancy 
 
Since the finding of the quiescent behavior of the CD133+ PC-3DsRed cells in the 
co-culture spheroid model reported in Chapter 2, the intuitive next step is to verify 
whether and how the quiescence of these CD133+ PC-3DsRed cells helps maintain their 
CD133 marker and keeps them “stem”-like.  This chapter describes efforts to explore the 
underlying molecular mechanisms that are governing the CD133+ PC-3DsRed cells in more 
depth by looking at their expression of key genes implicated in stem cell self-renewal, 
quiescence, homing, and localization.  The findings from these studies would provide 
insights and serve as the basis for subsequent consruction of a reporter system to allow 
real-time tracking of the CD133 expression in the PC-3 cells within the 3D co-culture 
constructs.  In addition to the prostate cancer cell proliferation data presented in Chapter 
2, we also took a step further to evaluate the quiescence of the prostate cancer cells 
cultured in the co-culture spheroids by looking at their cell cycling stage.  Here, we 
present preliminary data on current findings in therelevant stem cell gene expression 
profiles in the CD133+ subpopulation of PC-3 cells and the cell cycling stage of prostate 
cancer cells.  Additional efforts are required to elucidate the underlying mechanisms in 






5.1.1 Prostate Cancer Stem Cells 
 
Cancer stem cells (CSCs) contain genetic changes that define them as cancer cells; 
but unlike the bulk tumor population, they are not genetically unstable (Reya et al. 2001).  
Animal studies have showed that these small number (less then 2%) of CSCs within the 
tumor mass are the essential ones responsible for continual tumor growth and metastasis 
(Al-Hajj et al. 2003).  This implies that the “non-stem” majority of cancer cells in a 
tumor are not critical to target for treatment as they are genetically unstable and have 
limited ability to metastasize and grow.  Rather, CSCs’ lack of genetic instability 
represents a unique point of vulnerability, and therefore they are the essential targets to 
destroy to prevent cancers from metastasizing and killing the patients.  Therefore, 
establishing a method to enrich, maintain, and monitor these CSCs in vitro will be vital 
and powerful in future fundamental CSC biological studies and novel anti-cancer 
therapeutic developments. 
 
Recent studies have demonstrated the presence of CSCs in solid tumors such as 
breast, brain, pancreas, colon, and prostate cancers (Al-Hajj et al. 2003; Calabrese t al. 
2007; Ricci-Vitani et al. 2009; Cho and Clarke 2008; Ailles and Weissman 2007).  But 
the true identity of prostate CSCs has yet to be definitively defined.  Currently, prostate 
CSCs have been identified as the subpopulation of pr state cancer cells carrying the 
surface marker phenotype of CD44+/α2β1hi/CD133+ (Collins et al. 2005).  Specifically, 
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we have isolated the CD133+ subpopulation from the metastatic prostate cancer PC-3 cell 
line, which is believed to be more “progenitor-like.”  These cells have been shown to 
generate clones of additional stem cells as well as regenerating the heterogeneous 
population observed in the original tumor when passaged in mice.  However, it has not 
been possible to maintain and grow these cells ex vivo.  Several challenges that make the 
study and designs of therapies against them nearly impossible include: i) they can only be 
isolated in small numbers; and ii) they are very difficult to grow in vitro because the 
isolated CSCs undergo spontaneous programmed differentiation in in vitro cultures.  
Nevertheless, various CSC populations have been reported to be enriched and maintained 
in sphere cultures (Hirschhaeuser et al. 2010).  Recent studies have shown that CSCs 
from colorectal and brain cancers can only be maintained in 3D culture under serum-free 
conditions; whereas culturing of the CSCs under standard 2D monolayer conditions with 
serum-containing media led to loss of self-renewal, tumorigenic potential, and 
differentiation capabilities (Ricci-Vitiani et al. 2007; Lee et al. 2006).  As a result, 
culturing CSCs as conventional 2D monolayers is not a viable approach as in vitro 
models for developments of novel therapeutics.  To improve the current treatments and 
broaden the existing knowledge about cancer, it is crucial to develop cancer models 
involving these CSCs that possess the potent ability to regenerate tumors.   
 
5.1.2 Nest Parasitism Hypothesis and Tumor Dormancy 
 
Normal stem cells typically reside in microenvironmental niches in which cell 
fate decisions are regulated by surrounding cells, ECM components, and secreted local 
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and systemic factors (Dontu et al. 2005).  Likewise, CSCs are also likely to be 
maintained in a niche (Ailles and Weissman 2007).  In particular, several properties of 
prostate CSCs include: i) unlimited capacity for self-r newal; ii) use of the stromal 
derived factor-1 (SDF-1 or CXCL12) and its receptors CXCR4 or CXCR7 for migration 
and metastasis; iii) resistance to apoptosis and therapeutic agents targeting proliferating 
cells; iv) requirement for a specific microenvironment or niche to grow.  Interestingly, 
these characteristics are in direct parallel with normal HSCs properties. 
 
 For prostate cancer, bone is the most common metastatic ite; it provides various 
chemotactic, adhesion, and growth factors for prostate cancer to target and proliferate 
(Shiozawa et al. 2008).  Recently, it has been hypothesized that the prostate cancer bone 
metastasis process is very much similar to the migration and homing behavior of HSCs to 
the bone marrow niche (Shiozawa et al. 2008, 2010, 2011).  Given the complicated yet 
well-programmed process of HSCs self-renewal, proliferation, and differentiation, they 
must be tightly regulated within a physical locale, the HSC “niche” (Shiozawa et al. 
2008).  The HSC niche that regulates HSC homing, quiescence, and self-renewal is 
believed to be primarily comprised of osteoblastic (endosteal niche) and endothelial 
(vascular niche) cells as key components (Shiozawa et al. 2008).  Critical molecules such 
as chemoattractants (stromal derived factor-1, SDF-1 or CXCL12), attachment factors 
(annexin II or Anxa2), and regulators of cell growth involved in HSC niche selection are 
also thought to be used by prostate cancer metastases o the bone.  Once prostate cancer 
cells home to the bone marrow, they parasitize the bone microenvironment to regulate 
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their long-term survival, dormancy, and ultimately metastatic growth (Figure 5.1).  
Recently, Shiozawa et al. have proven this concept (Shiozawa et l. 2008, 2010, 2011). 
 
In a mouse model of metastasis, disseminated human prostate cancer cells from 
primary tumors directly compete with HSCs for occupancy of the HSC niche (Shiozawa 
et al. 2011).  HSCs and prostate cancer cells also colocalize to the endosteal bone 
surfaces of the bone marrow niches both in vivo and in vitro (Shiozawa et al. 2011).    
Initially, like HSCs, prostate cancer cells utilize the CXCR4/SDF-1 pathway to migrate 
and gain access to the bone marrow during metastasis to the bone (Sun et al. 2003, 2005., 
Wang et al. 2008).  Engagement of SDF-1 receptors on PCa cells subsequently leads to 
increased expression of the adhesive-localization mlecule annexin II, which has been 
shown to bind both PCa cells and HSCs to osteoblasts in the endosteal niche (Shiozawa 
et al. 2008; Taichman et al. 2007).  Altogether, these findings suggest that fac ors from 
the HSC niche are critical in the osteotropism of pr state cancer metastasis to the bone. 
 
The role of the HSC niche (in particular, the endosteal or osteoblast niche) is also 
thought to induce and maintain HSC quiescence (dormancy) and regulate differentiation 
(Shiozawa et al. 2010, 2011).  Since metastatic PCa cells occupy the same niche as HSCs, 
it is likely that the molecules involved in the induction of HSC dormancy also induce 
dormancy in metastatic PCa cells.  Shiozawa et al. have showed that the GAS6/AXL axis 
plays a critical role in regulating the quiescence and survival of prostate cancer in the 
HSC niche (Shiozawa et al., 2010).  Specifically, it was first demonstrated that the 
binding of prostate cancer cells to annexin II induces the expression of GAS6 receptor 
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AXL in prostate cancer cells (Shiozawa et al., 2010).  AXL binding to GAS6 produced 
by osteoblasts inhibited prostate cancer cell proliferation and induces quiescence of 
prostate cancer cells as shown by an increased fraction of cells in the G0 cell cycle state 
and a decreased fraction in the G1 and S/M/G2 states (Shiozawa et al., 2010).  Based on 
these data, it is likely that the activation of GAS6 receptor AXL on the metastasized 
prostate cancer cells in the marrow environment plays  critical role as a molecular 
switch to establish dormancy and thus protects prostate cancer cells from chemotherapy.  
As a result, these mechanisms together support the concept that metastatic prostate cancer 
cells target the HSC niche during metastasis and serve as molecular parasites of the HSC 
niche by hijacking the normal machinery in the niche to facilitate their survival, 
dormancy, and growth. 
 
 Based on the nest parasitism hypothesis, we have already adapted 3D spheroid 
culture to engineer in vitro 3D prostate cancer bone micrometastases from the CD133+ 
PC-3DsRed cells as innovative co-culture constructs in an effort to maintain their 
progenitor cell properties in Chapter 2.  We showed that the CD133+ PC-3DsRed 
subpopulation was relatively quiescent when cultured in co-culture spheroids with 
endothelial cells and osteoblasts.  Because the CD133+ PC-3DsRed did not divide but 
remained dormant, it is very likely that their CD133 marker was also maintained.  Here, 
we describe efforts to develop a reporter system to allow tracking of prostate cancer 
progenitor cell properties in real-time by correlating the CD133 marker of PC-3 cells to 
the expression of key genes relevant in stem cell self-renewal, quiescence, migration, and 
localization.  Specifically, the genes we looked at include Bmi-1, a gene implicated in 
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stem cell self-renewal regulation, and its downstream target Ink4a (Park et al. 2004; 
Iwama et al. 2004; Lessard and Sauvageau 2003).  Additionally, we looked at the 
expression of the two important receptors for SDF-1—CXCR4 and CXCR7, which are 
essential elements in the migration and homing of hematopoietic stem cells (HSCs) and 
prostate cancer metastasis to the bone marrow niche(Sun et al. 2003, 2005., Wang et al. 
2008).  The expression of Annexin II receptor (Anxa2R) that plays a significant role in 
the binding and localization of prostate cancer cells to the osteoblasts in the bone marrow 
niche (Shiozawa et al. 2008) was also investigated.  Finally, we explored the expression 
levels of three receptors for GAS6—the AXL family of receptor tyrosine kinases (AXL, 
Sky, and Mer), which are regulators of cell growth and quiescence in the hematopoietic 
system as well as prostate cancer metastasis to the bone (Shiozawa et al. 2010).  These 
essential genes implicated in HSCs and metastatic prostate cancer cells are expected to be 
up-regulated in the subpopulation of prostate cancer cells enriched for CSCs. 
 
Since the eventual goal of establishing an accurate in vitro model of prostate 
cancer bone metastasis niche containing dormant pros ate CSCs is to use it as a basis for 
the development of novel types of anti-cancer therapy, we transferred the culture of the 
PC-3 co-culture spheroids from the microfluidic devic  mentioned in Chapter 2 to the 
high-throughput hanging drop platform developed in Chapter 3.  The characterization of 
PC-3 growth rate in the 3D co-culture spheroids maintained in the 384 hanging drop plate 
was also performed.  To confirm the quiescent behavior of the prostate cancer cells 
observed in Chapter 2, we also initiated studies to explore the cell cycling stage of 





5.2 Materials and Methods 
 
5.2.1 General Cell Culture 
 
PC-3DsRed metastatic prostate cancer cells stably transfected with DsRed), human 
umbilical vein endothelial cells (HUVECs), and MC3T3-E1 mouse pre-osteoblasts are 
cultured and maintained as described in Chapter 2, Section 2.2.1—General Cell Culture.  
PC-3Luc GFP (mesenchymal PC-3 cells that have already undergon epithelial-
mesenchymal transition (EMT), and stably transfected with luciferase and GFP) and PC-
3Luc E GFP (epithelial PC-3 cells that have not undergone EMT, and stably transfected with 
luciferase and GFP) are cultured in the same way as PC-3DsRed cells. 
 
5.2.2 PC-3DsRed CD133+ Cell Sorting 
 
PC-3DsRed CD133+ and CD133- cells were isolated using CD133 Cell isolation kit,
according to the manufacturer’s protocol (Miltenyl Biotec) as described in Chapter 2, 
Section 2.2.7—PC-3DsRed CD133+ Cell Sorting. 
 





PC-3DsRed CD133+ and CD133- subpopulations of cells are further sorted for 
CD44+ and CD44- subpopulations (Figure 5.3a), or Anxa2R+ and Anxa2R- 
subpopulations (Figure 5.3a) using FACS Vantage dual-laser flow cytometer (Becton 
Dickinson) following staining with anti-Human CD44 antibodies (BD Pharmingen, San 
Diego, CA) or anti-Anxa2R antibodies.  Annexin II p11 peptides (S100A10 (human) 
Recombinant Protein, Thermo Scientific, Rockford, IL) were used as antibodies for 
Anxa2R because Anxa2R was previously shown to bind to the p11 subunit of Annexin II 
(Lu et al. 2006).  Annexin II p11 peptides were labeled with fluorescent dye prior to flow 
sorting using Alexa Fluor® 488 Microscale Protein Labeling Kit (A30006, Molecular 
Probes, Eugene, OR) according to manufaturer’s protocol.  PC-3DsRed cells were then 
sorted for Anxa2R+ and Anxa2R- subpopulations using these fluorescent (Alexa Fluor® 
488) conjugated p11 peptides. 
 
5.2.4 RNA Extraction and QRT-PCR 
 
QRT-PCR was performed using standard techniques.  Total RNA was isolated 
using RNeasy Mini Kit (Qiagen, Valencia, CA), and first-strand complementary DNA 
(cDNA) was synthesized with 0.8 µg of total RNA in a 40 µl reaction volume.  Reverse 
transcript products were analyzed by QRT-PCR in TaqMan Gene Expression Assays of 
several target genes including Bmi-1, Ink4a, CXCR4, CXCR7, Anxa2R, AXL, Sky, Mer, 
and β-Actin (Applied Biosystems, Foster City, CA).  QRT-PCR analysis was carried out 
using 15.0 µl of TaqMan Universal PCR Master Mix (Applied Biosystems), 1.5 µl of 
TaqMan Gene Expression Assay, 1 µl of cDNA, and 12.5 µl of RNAse/DNAse-free 
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water in a total volume of 30 µl.  Negative controls were reactions without template.  The 
initial single cycle of 95°C for 15 minutes to activate the Taq polymerase was followed 
by 40 cycles of second step PCR (95°C for 30 seconds a  60°C for 1 minute).  The PCR 
product was detected as an increase in fluorescence using an ABI PRISM 7700 sequence 
detection system (Applied Biosystems).  RNA quantity (CR) was normalized to the 
housekeeping gene β-Actin control by using the formula CR = 2(40 – Ct of sample) – (40 – Ct of 
control).  The threshold cycle (Ct) is the cycle at which a significant increase in fluorescence 
occurs. 
 
5.2.5 Formation and Culture of PC-3DsRed, PC-3Luc GFP, and PC-3Luc E GFP Co-culture 
Spheroids with HUVEC and MC3T3-E1 Cells in the 384 Hanging Drop Array Plate 
 
 
Cell suspensions for the hanging drop experiments were made by dissociating 
cells with 0.25% trypsin-EDTA (Gibco 25200, Invitrogen Co.), centrifugation of 
dissociated cells for 5 minutes, and re-suspended in the complete growth media of the 
specific cell types.  Cell densities of each cell type were estimated using a 
hemocytometer.  PC-3DsRed (or PC-3Luc GFP or PC-3Luc E GFP), HUVEC, and MC3T3-E1 
heterogeneous cell suspension was then pre-mixed at 1:50:50 ratio prior to seeding in the 
384 hanging drop array plate.  Consequently, the co-culture media consists of PC-3 
complete growth media, HUVEC endothelial growth medium-2 (EGM-2), and MC3T3-





The pre-mixed heterogeneous cell suspension was subeq ently formed into 
hanging drops in the second generation modified 384 hanging drop array plates described 
in Chapter 4.  The hanging drop formation process wa carried out using the standard 
protocol as previously described in Chapter 3 with a minor increase in the hanging drop 
volume to accommodate the larger volume allowed by the second generation plates.  
Briefly, on the spheroid culture plate, a 20 µl heterogeneous cell suspension was 
dispensed into the bottom surface of the access hole at each cell culture site to form a 
hanging drop.  In order to prevent evaporation, 4 ml of distilled water was added into the 
peripheral water reservoir.  In addition, the plate was sandwiched by a 96-well plate lid 
and plate filled with distilled water, and wrapped in Parafilm.  The growth media was 
exchanged every other day by taking 8 µl of media from a drop, and adding 10 µl of fresh 
co-culture media into a drop to account for minor evaporation of the original drop.  1200-
cell co-culture spheroids were formed for the PC-3 proliferation experiments; and 3000-
cell co-culture spheroids were formed for the subsequent cell cycling stage analysis (to 
ensure enough PC-3 cells for analysis by flow cytometry). 
 




Once the prostate cancer co-culture spheroids are formed in the 384 hanging drop 
plates, the spheroids were cultured and monitored for 7 days in the PC-3 proliferation 
characterization experiments.  Co-culture spheroids cultured in the 384 hanging drop 
array plates were imaged by phase contrast microscopy as well as fluorescence 
microscopy (Nikon TE-300).  The number of PC-3DsRed cells within each spheroid was 
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tracked by fluorescence everyday for a total of 7 days.  On the last day (Day 7) of culture, 
the spheroids were stained with calcein-AM (L3224, Invitrogen) to evaluate cellular 
viability.  5 µl of calcein-AM working solution dissolved in PBS to a concentration of 
5µg/ml was added directly into the 20 µl hanging drops (final calcein-AM concentration 
of 1µg/ml) and incubated for 30 minutes at 37oC. 
 
PC-3DsRed doubling time calculation for the co-culture spheroids was slightly 
modified from the method described in Chapter 2.  The modified calculation method is 
believed to provide a more accurate estimate of the doubling time.  Briefly, PC-3DsRed 
doubling time inside the co-culture spheroids was clculated by fitting an exponential-fit 
line through the PC-3DsRed proliferation graph of each spheroid sample (number of PC-
3DsRed cells/spheroid vs. time).  The equation obtained from each fit was subsequently 
used to solve for the time it takes for the initial number of PC-3DsRed cells per spheroid at 
day 1 to double.  The final doubling time was determined to be the time it takes for the 
PC-3DsRed cells present at day 1 to double.  The same method was used to calculate the 
doubling time of all PC-3DsRed co-culture spheroid samples.  The average and standard 
error were then calculated from the estimated doubling time for each co-culture spheroid 
sample.  
 
5.2.7 Spheroid Retrieval for Flow Cytometry Analysis 
 
For the cell cycling stage analysis experiments, spheroids were cultured and 
monitored for 14 days to allow sufficient time for the prostate cancer cells to adapt to the 
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3D co-culture environment.  Co-culture spheroids cultured in the 384 hanging drop array 
plates were imaged by phase contrast microscopy as well as fluorescence microscopy 
(Nikon TE-300) every other day.  On Day 14, spheroids were retrieved from the 384 
hanging drop plates and pooled for evaluation of the prostate cancer cell cycling stage.  
With the simple liquid handling procedures offered by the 384 hanging drop plate, 
spheroids were easily harvested by direct pipetting.  Upon co-culture spheroids retrieval 
(enough spheroids were collected to ensure that there are at least 10,000 prostate cancer 
cells to analyze), the spheroids were gently broken up into single cells using enzyme-free 
cell dissociation buffer with 1 hour incubation time and gentle pipetting.  After spheroids 
were broken into single cells, the cell suspension was centrifuged to remove cell 
dissociation buffer and fixed in BD Cytofix (554655, BD Biosciences) overnight. 
 
5.2.8 Cell Cycling Assays 
 
Cell cycle status of the prostate cancer cells in these co-culture spheroids and 
conventional 2D mono-cultures were analyzed by FACS using propidium iodide (PI, 
Molecular Probes) and Ki-67 staining methods.  Ki-67 antibody was conjugated to APC-
Cy7 using Lightning-Link APC-Cy7 Tandem Conjugation Kit (Innova Biosciences) 
following manufacturer’s protocol.  Cell samples were first treated with saponin to 
permeabilize cell membranes without destroying them.  PC-3Luc GFP or PC-3Luc E GFP cells, 
HUVECs, and MC3T3-E1 cells from 2D mono-cultures were pre-mixed at equal ratios to 
obtain samples with heterogeneous cell mixtures.  Thereafter, cells were simultaneously 
incubated in 50 µg/ml of PI and Ki-67 conjugated antibody for 1 hour.  The cell cycle 
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state was analyzed by flow cyometry (BD FACSAria II Flow Cytometer, Becton 
Dickinson).  We specifically look for the prostate cancer cell population, which is the 
only cell type within the sample mixtures that stably expresses GFP.  Since the intensity 
of the PI signal is directly proportional to DNA content, a histogram of the PI intensity 
was plotted on the linear scale to identify peaks that signify cell in the G0/G1 phase, S 
Phase, and G2/M phase.  The prostate cancer cell population was also analyzed for 
negative Ki-67 staining, which indicates that the cells are in the quiescent G0 state. 
 
 
5.3 Results and Discussion 
 
5.3.1 Gene Expression Profiles in CD133+ and CD133- PC-3DsRed Cells 
 
 In an effort to develop a reporter system to monitor the maintenance of the CD133 
progenitor marker on PC-3DsRed cells in real-time, we started the initiative to look at the 
expression profiles of several stem cell-relevant genes in the CD133+ and CD133- 
subpopulations of PC-3DsRed cells.  The rationale is that if we can identify and correlate 
key stem cell-related genes to the presence of CD133 in PC-3DsRed cells, then a luciferase 
construct could be placed under the promoter control of the target gene of interest, and 
transfect the construct into PC-3DsRed cells.  Real-time monitoring of the presence of the 




PC-3DsRed cells were sorted for CD133+ and CD133- subpopulations for a total of 
two times (designated as batch I and batch II).  Both batches were evaluated for the 
expression levels of 8 critical genes implicated in the self-renewal, homing, localization, 
and quiescence of HSCs and metastatic prostate cancer cells (Bmi-1, Ink4a, CXCR4, 
CXCR7, Annexin II receptor, AXL, Sky, and Mer) in two repeat trials.  Figure 5.2a and b 
summarize the results obtained from the evaluation of these 8 gene expression levels in 
the two batches of sorted CD133+ and CD133- PC-3DsRed cells from two separate trials.  
Unfortunately, no correlation was found between the CD133 marker of prostate cancer 
progenitor cell and the 8 genes investigated.  The results obtained were not consistent 
between the two different batches of sorted CD133+ and CD133- cells, and between the 
two independent trials.  Since the data obtained was not conclusive we were not able to 
proceed to the construction and transfection of the proposed luciferase construct. 
 
5.3.2 CD44+, CD44-, Anxa2R+, and Anxa2R- Subpopulations 
 
Because the gene expression profile data we obtained from the PC-3DsRed cells 
sorted for CD133+ and CD133- was inconclusive, we hypothesized that merely sorting for 
the CD133 marker did not produce a pure population for prostate cancer progenitor cells.  
Therefore, we proceeded to sort the CD133+ and CD133- populations of PC-3DsRed cells 
further into CD44+ and CD44-, or Anxa2R+ and Anxa2R- subpopulations (Figure 5.3a).  
Figure 5.3b and Table 5.1 show the sorting statistics of the CD44+ and Anxa2R+ 
subpopulations from two independent sorting trials from two batches of cells.  In both 
batches, the CD133+ PC-3DsRed population seems to be enriched in both CD44+ and 
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Anxa2R+ cells.  In the first batch, only about 5% of the CD133- PC-3DsRed cells are 
CD44+, but 90% of the CD133+ PC-3DsRed cells are CD44+.  Similarly in the second batch, 
only less than 1% of CD133- PC-3DsRed cells are CD44+, but 66% of the CD133+ PC-
3DsRed cells are CD44+.  For Anxa2R sorting, we see a larger difference in the 
subpopulation percentages between the two batches of cells.  Nevertheless, the overall 
trend is still the same.  Only about 0.4% of the CD133- PC-3DsRed cells are Anxa2R+, but 
3% of the CD133+ PC-3DsRed cells are Anxa2R+ in the first trial.  In the second batch, we 
see a huge increase in the percentage of Anxa2R+ cells with 9% of the CD133- PC-3DsRed 
cells being Anxa2R+ and 70% of the CD133+ PC-3DsRed cells being Anxa2R+. 
 
Next, we looked at the expression levels of three sl ct stem cell genes that 
seemed more relevant and consistent in previous results—Bmi-1, Ink4a, and Anxa2R in 
all the eight sorted subpopulations.  Figure 5.4a show  the overall results and Figure 5.4b 
highlights the comparison only between the double negative (–/–) and double positive 
(+/+) cell populations.  Again, we found inconsistency in the gene expression level 
profiles between these two different sorted batches of cells.  Since no strong correlation 
was found between the genes relevant in stem cells and the prostate cancer stem cell-
enriched populations, we were not able to proceed in eveloping a reporter system to 
monitor the CD133 marker in PC-3DsRed cells.  As a result, we have not successfully 
found a method to validate the maintenance of stem- or progenitor-like conditions in the 
quiescent CD133+ PC-3DsRed co-culture spheroids reported in Chapter 2. 
 
5.3.3 PC-3DsRed Growth and Viability in Co-culture Spheroids Cultured in the 384 





 To lay the foundation for future anti-cancer drug screening experiments, the 
culture of PC-3DsRed, HUVEC, and MC3T3-E1 in co-culture spheroids as an in vitro 
model for metastatic prostate cancer niche was scaled up to a high-throughput format in 
the second generation 384 hanging drop array plates described in Chapter 4.  Due to the 
change in culture platform and the increase in co-culture spheroid size, PC-3DsRed cell 
proliferation within the 3D co-culture constructs was characterized again.  PC-3DsRed cells 
were tracked for their proliferation within each spheroid by their red fluorescence 
everyday for 7 days.  Figure 5.5a to c show the overall growth pattern and viability of the 
PC-3DsRed cells within the 3D co-culture spheroids over the course of 1 week.  Figure 5.5a 
shows the optical and fluorescent time-lapse images of a representative PC-3DsRed, 
HUVEC, and MC3T3-E1 co-culture spheroid.  It is clear from both the phase and 
fluorescent images that PC-3DsRed cells were still able to actively proliferate inside the co-
culture spheroids.  Moreover, PC-3DsRed cells were still alive after 7 days of culture inside 
the co-culture spheroid as shown in Figure 5.5b with a live viability staining image 
obtained using fluorescent microscopy.  Green cells stained with calcein-AM indicate 
live cells whereas red cells were PC-3DsRed cells that expressed red fluorescence.  Since 
almost all the red cells overlap with the viable gren color, most PC-3DsRed cells were able 
to survive under the hanging drop 3D co-culture enviro ment after 7 days in culture.  
Figure 5.5c summarizes the overall proliferation trend of PC-3DsRed cells cultured in the 
co-culture spheroids as hanging drops.  As found in the results from Chapter 2, PC-3DsRed 
cells proliferated at a relatively slow rate in 3D co-culture spheroids compared to 
conventional 2D monolayer mono-cultures.  However, as we calculated the doubling time 
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of the PC-3DsRed cells under the 3D co-culture hanging drop environme t, we found an 
obvious decrease in the doubling time estimation frm the result presented in Chapter 2.  
The PC-3DsRed doubling time in the hanging drop platform was estima ed to be 87 hours 
(80 hours if calculated using the original doubling time estimation method described in 
Chapter 2) while it was estimated to be around 200 hours (Table 2.1) in the original study.  
Although the growth rate of PC-3DsRed cells inside 3D co-culture spheroids in the hanging 
drop platform is found to be about 2.5 times faster than in the microfluidic device, such 
proliferation rate of PC-3DsRed cells in 3D co-culture environment is still much slower 
than the 24 hour doubling time of PC-3DsRed cells in conventional 2D mono-culture 
(Table 2.1).   
 
It is postulated that perhaps the higher initial seeding number (1200-cell spheroids 
in hanging drop plate versus the 300- to 400-cell spheroids in microfluidic device) has an 
effect on the overall growth rate of the PC-3DsRed cells in the 3D co-culture spheroids.  
Higher number of PC-3DsRed cells aggregated closely inside a larger compacted 3D co-
culture spheroid construct, where diffusion and transport are less efficient than smaller 
spheroid, consequently leads to secretion of more autocrine factors localized within the 
spheroid and therefore seen at higher concentrations by the individual PC-3DsRed cells.  If 
the growth rate of the PC-3DsRed cells in the larger spheroids was already faster than in the 
smaller spheroids, then the condition could even be exacerbated as PC-3DsRed cells start to 
proliferate and out number the support cells.  Although the co-culture ratio between these 
independent experiments was kept constant, but becaus  the HUVEC and MC3T3-E1 
support cells mainly remain quiescent, it is also plausible that secreted factors from the 
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neighboring support cells to keep PC-3DsRed cells quiescent would be diluted out to lower 
concentrations not enough to induce dormancy of the PC-3DsRed cells.   
 
5.3.4 Cell Cycling Stage of PC-3Luc GFP and PC-3Luc E GFP Cells in Co-culture Spheroids 
 
To explore whether the 3D co-culture spheroid constructs induce prostate cancer 
cells into dormant states, cell cycling states were valuated by flow cytometry.  We 
specifically looked for and compared the cell cycling states from two types of PC-3 
populations—mesenchymal PC-3Luc GFP cells that have been characterized to have already 
undergone EMT and epithelial PC-3Luc E GFP cells that have not undergone EMT.  3000-
cell PC-3, HUVEC, MC3T3T-E1 co-culture spheroids were formed and cultured from 
both types of PC-3 cells, and the PC-3 population was analyzed for their cell cycling 
states on Day 14.  The phase and fluorescent time-lapse images for both PC-3 cell types 
cultured in the co-culture spheroids were shown in Figure 5.6a and b.  From both the 
phase and fluorescent images, it is very obvious that both PC-3 cell types proliferated 
over the 14 days of culture.  No obvious difference was observed between these two 
types of PC-3 cells.   
 
Figure 5.7 and Figure 5.8 show the results obtained from PI and Ki-67 staining of 
PC-3Luc GFP cells, respectively.  And Figure 5.9 and Figure 5.10 show the results obtained 
from PI and Ki-67 staining of PC-3Luc E GFP cells, respectively.  The results obtained from 
the 3D co-culture spheroid samples were also compared to the cell cycling states of the 
same types of PC-3 cells cultured in conventional 2D monolayer mono-cultures.  Again, 
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no obvious difference was found in the cell cycling states of the mesenchymal PC-3Luc 
GFP cells and the epithelial PC-3Luc E GFP cells.  From the PI staining results, no obvious 
G0/G1 peak was identified for both mesenchymal and epithlial PC-3 cell types in both 
2D mono-culture and 3D co-culture samples.  Most of the cells were found in the S and 
G2/M phases of the cell cycle (Figure5.7, Figure 5.9, and Table5.2).   This signifies that 
the majority of both types of PC-3 cells cultured in either 2D mono-cultures or 3D co-
cultures are in their actively proliferating states.  These results are further confirmed by 
KI-67 staining results presented in Figure 5.8 and Figure 5.10.  Almost all cells from both 
PC-3 cells types cultured in either 2D mono-cultures or 3D co-culture spheroids are Ki-
67+.  This indicates that almost all cells are in the G1 and S/M/G2 states.  3D co-culture 
condition did not increase the fraction of PC-3 cells in the quiescent G0 state.  Thus, 
dormancy of prostate cancer cells was not induced in the 3D co-culture spheroids.  These 
results are also in accordance with our visual observation as shown in Figure 5.6. 
 
Although quiescence was not found to be induced in the PC-3 cells cultured in the 
3D co-culture spheroids, it should be noted that these are the bulk population of PC-3 
cells.  Further experiments are required to characte ize the proliferation and cell cycling 
state of the CD133+ subpopulation of PC-3 cells that were found to be quiescent within 
the co-culture spheroids in Chapter 2.  It is very likely that it is only the CD133+ 
population and not the bulk prostate cancer population that is more quiescent in the bone 
marrow niche.  Proving such concept would support the CSC hypothesis that only CSCs 
are able to establish metastasis, remain dormant, escap  from anti-cancer treatments such 







We describe efforts to study the underlying mechanisms in regulating prostate 
cancer stem cells and tumor dormancy in more detail.  Specifically, we first explored the 
relationship between several stem cell-relevant genes and the CD133+ prostate cancer cell 
population believed to be enriched in CSCs in an effort to develop a reporter system to 
track the maintenance of the CD133 marker in prostate c ncer cells.  Although the results 
were inconsistent, we were prompted to study prostate CSCs utilizing alternative 
approaches from the tumor dormancy perspective.  We subsequently scaled up the PC-3 
co-culture spheroids culture as in vitro 3D models of prostate cancer bone metastasis in a 
high-throughput format using the 384 hanging drop plates in preparation for future drug 
screening initiatives.  While utilizing the hanging drop platform, we showed that PC-3 
cells still actively proliferate in the co-culture spheroids, and thus dormancy of the bulk 
prostate cancer cell population was not induced by 3D co-culture.  We also obtained 
valuable insights that the co-culture ratios and the absolute initial cell seeding numbers 
may have an effect in prostate cancer cell growth be avior.  This is in accordance with 
the clinical observation that very few numbers of disseminated tumor cells metastasized 
to distant sites such as the bone marrow niche could remain dormant for a long time in 




A lot of the findings and concepts presented in this chapter are still current work 
in progress.  Much effort is still needed to investigate the prostate CSC-enriched CD133+ 
population in more detail.  Specifically, the proliferation pattern, quiescence, and 
maintenance of stem or progenitor cell properties of the CD133+ prostate cancer cells 
should be well-characterized in the 3D co-culture spheroids.  The proliferation 
characterization and quiescence validation can be analyzed by the same techniques 
presented in this chapter.  The presence of the CD133 marker could also be confirmed by 
flow cytometry.  Most importantly, efforts should be devoted to explore the molecular 
mechanisms in inducing the CD133+ prostate cancer cells in the co-culture spheroids into 
dormant state as seen in Chapter 2.  We have already initiated studies to elucidate such 
underlying mechanisms by evaluating the quiescence of prostate cancer cells co-cultured 
with support cells (specifically the MC3T3-E1 mouse pre-osteoblasts) that have 
knockdowns of various key molecules implicated in tumor dormancy—GAS6, Annexin 
II, SDF-1, TGFβ, and BMP7.  Another important question to address is whether the 
dormant state of CD133+ prostate cancer cells is able to maintain their CD133 marker and 
thus keep their as stem- or progenitor-like properties.  As these significant biological 
questions are unraveled, it would be easy to successfully engineer an accurate in vitro 3D 
metastatic prostate cancer bone marrow niche to culure and maintain CSCs in their stem-
like and dormant states using our high-throughput hanging drop platform.  An in vitro 
niche containing a pure and quiescent prostate CSC population will serve as an accurate 
and excellent model to screen and test for drugs that specifically target the dormant 
metastasized prostate cancer cells.  Such an in vitro bone metastasized prostate cancer 
model reflective of the actual dormant tumor in them tastatic niche in vivo is an integral 
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part in the success of novel anti-cancer therapeutic development.  Findings in the 
molecular mechanisms involved in inducing tumor dormancy will provide significant 




Figure 5.1.  Schematic cartoon illustrating the nest parasitism hypothesis of prostate 
cancer metastasis to the bone, highlighting the homing, binding, and quiescence 




Figure 5.2.  Bmi-1, Ink4a, AXL, Sky, Mer, CXCR7, CXCR4, and Anxa2R mRNA 
expression levels of CD133+ and CD133- subpopulations of the PC-3DsRed cell line as 
determined by real time RT-PCR.  Data obtained from sorted Batch I of cells are 
designated with “I,” and similarly Batch II cells are designated with “II.”  Results from 
trial 1 are shown in (a), and results from trial 2 are shown in (b).  Data were normalized 




Figure 5.3.  (a)  Organizational charts outlining the sequential sorting process of PC-
3DsRed cells into various subpopulations.  (b)  Flow cytometric analysis of the percentages 
of CD44+ (left 2 columns) or Anxa2R+ (right 2 columns) subpopulations within the 
CD133- and CD133+ PC-3DsRed cells.  The first row of flow cytometric data reprsent data 
from the first sorting batch of cells, and the second row of data represent data from the 




Figure 5.4.  (a) Bmi-1, Ink4a, and Anxa2R mRNA expression levels of the various 8 
different subpopulations (See Figure 5.3a) of the PC-3DsRed cell line as determined by real 
time RT-PCR.  (b) Bmi-1, Ink4a, and Anxa2R mRNA expression levels data from (a), 
but only showing results from the 4 double negative and double positive PC-3DsRed 
subpopulations (See Figure 5.3a)—CD133-/CD44-, CD133+/CD44+, CD133-/Anxa2R-, 





Figure 5.5.  (a)  Phase and fluorescent time-lapse images of a repres ntative 1200-cell 
PC-3DsRed, HUVEC, and MC3T3-E1 1:50:50 co-culture spheroid showing PC-3DsRed 
proliferation over 7 days in the hanging drop culture.  (b)  A fluorescent image of live 
calcein-AM staining overlapped with the red fluoresc nce from PC-3DsRed cells within the 
co-culture spheroid illustrating the viability of PC-3DsRed cells.  Red = PC-3DsRed cells, 
Green = Live cells (calcein-AM stain), Yellow = Live PC-3DsRed cells.  (c) Graph of PC-
3DsRed proliferation pattern inside co-culture spheroids over a course of 1 week.  Y-axis 
shows the average number of PC-3DsRed cells per spheroid, and x-axis is the time in days.  




Figure 5.6.  Phase and fluorescent time-lapse images of a representative 3000-cell (a) 
epithelial PC-3Luc E GFP and (b) mesenchymal PC-3Luc GFP spheroid co-cultured with 
HUVEC and MC3T3-E1 cells at 1:50:50 ratio, showing PC-3DsRed proliferation over 14 
days in the hanging drop culture. 
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Figure 5.7.  Flow cytometric analyses of PI staining in mesenchymal PC-3Luc GFP cells 
from 2D mono-culture and 3D co-culture spheroid samples showing the percentages of 
cells in each of the G0/G1, S, and G2/M cell cycling states.  Each histogram represents 
data from (a) 2D mono-culture unstained control, (b) 2D mono-culture stained sample, (c)
3D co-culture spheroid unstained control, (d) 3D co-culture spheroid stained sample 1, 







Figure 5.8.  Flow cytometric analyses of Ki-67 staining in mesenchymal PC-3Luc GFP cells 
from 2D mono-culture and 3D co-culture spheroid samples showing the percentages of 
cells that are Ki-67+ (G1, S, G2, and M states of cell cycle).  Each histogram represents 
data from (a) 2D mono-culture unstained control, (b) 2D mono-culture stained sample, (c)
3D co-culture spheroid unstained control, (d) 3D co-culture spheroid stained sample 1, 







Figure 5.9.  Flow cytometric analyses of PI staining in epithelial PC-3Luc E GFP cells from 
2D mono-culture and 3D co-culture spheroid samples showing the percentages of cells in 
each of the G0/G1, S, and G2/M cell cycling states.  Each histogram represents da a from 
(a) 2D mono-culture unstained control, (b) 2D mono-culture stained sample, (c) 3D co-
culture spheroid unstained control, (d) 3D co-culture spheroid stained sample 1, and (e) 







Figure 5.10.  Flow cytometric analyses of Ki-67 staining in epithelial PC-3Luc E GFP cells 
from 2D mono-culture and 3D co-culture spheroid samples showing the percentages of 
cells that are Ki-67+ (G1, S, G2, and M states of cell cycle).  Each histogram represents 
data from (a) 2D mono-culture unstained control, (b) 2D mono-culture stained sample, (c)
3D co-culture spheroid unstained control, (d) 3D co-culture spheroid stained sample 1, 








Table 5.1. Summary of CD44+ and Anxa2R+ subpopulations found in CD133- and 




Table 5.2. Summary of the cell cycling state of mesenchymal and epithelial PC-3 cells 
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Conclusion and Future Direction 
 
Cancer is a devastating disease that has greatly influenced the lives of many.  
Despite vast amount of research and efforts dedicated to cancer biology in the past 
several decades, cancer still remains incurable to da e.  Recent conception of the cancer 
stem cell (CSC) hypothesis possesses great potential to offer revolutionary advancements 
in understanding cancer and developing novel anti-cancer therapeutics from a different 
perspective.  Particularly, the dormancy stage of cancer thought to be maintained by 
quiescent CSCs before the subsequent uncontrolled mtastatic outbreak is a key 
intervention point of interest.  Unfortunately current in vitro models of cancer do not 
faithfully recreate the in vivo complex metastatic environment, and the maintenance of 
CSCs in vitro has not been possible.  The ability to reproduce an accurate metastatic 
microenvironment to maintain CSCs in vitro will provide new insights into cancer 
biology and anti-cancer drug discovery.  The work described in this dissertation 
represents efforts toward this goal with sophisticated utilization of micro-technologies for 
3D spheroid culture as a compelling solution to the development of such model. 
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6.1 Overall Contributions 
 
Development of in vitro culture systems that properly model the growth behavior 
and microenvironment of cancer cells is essential for advancing the understanding of 
cancer biology and therapeutic design.  This dissertation research contributed to the field 
of cancer biology by using micro-technologies to integrate complex tumor 
microenvironment components into an in vitro metastatic niche model that recapitulates a 
more physiologically-relevant growth characteristic of prostate cancer cells.  This 
interdisciplinary research effort represents advancements in both biotechnological 
development and cancer research.  Technologically we developed innovative 3D culture 
platforms for use in fundamental biological studies and drug discovery, and continually 
demonstrated additional system improvements throught the works described in this 
dissertation.  Biologically we established an in vitro prostate cancer metastasis bone 
marrow niche model and used it to gain insights into the biology of tumor dormancy 
regulation. 
 
6.1.1 Technological Innovations 
 
Micro-technologies offer great advantages to reproduce in vivo-like conditions in 
an accurate manner in vitro.  The microfluidic spheroid culture device described in 
Chapter 2 represents an initial step in advancing current 3D culture systems and in 
establishing an accurate in vitro model reflective of the complex in vivo prostate cancer 
metastatic niche in the bone marrow.  By integrating microfluidics, the system allows for 
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efficient formation and uniform control of 3D spheroids not otherwise possible in 
conventional methods.  From a more practical perspective, the versatility of such 3D 
spheroid culture system to generate accurate in vitro models and its impact on biomedical 
sciences will be increased with the integration of simple fabrication process and high-
throughput capabilities.  Through the work described in Chapter 3, we have made such 
improvement in scaling up efficient formation and culture of 3D spheroids as hanging 
drops in a high-throughput format. 
 
The 384 hanging drop array plate, offers high-throughput microscale 3D cell 
culture as accurate tissue or tumor constructs to obtain more in-depth knowledge of 
essential biological processes, model pathological diseases, and screen for novel 
therapeutics.  We have revolutionized the approach to conventional hanging drop 3D 
spheroid cultures by turning droplet fluidics into a simple, user-friendly platform to 
enable practical use by a vast range of biomedical isciplines.  This system has several 
compelling attributes such as material compatibility with hydrophobic drugs and 
standardized design compatibility with high-throughput screening instruments that can 
make a significant contribution to delivering the potential of expediting medical 
innovation and drug discovery processes.   
 
For the plate to become more widely adopted, the system must not just provide 
high-throughput feature, but it should also feature a simple user-interface and be readily 
available.  The hanging drop formation process in the platform makes 3D spheroid 
culture as straightforward as routine 2D cell culture.  Furthermore, since the 384 hanging 
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drop plate is fabricated by injection molding, we have established a platform that not only 
is user-friendly and cost effective, but can also be mass produced as an integral tool for 
immediate translational research applications.  The platform greatly reduces the 
complexity of microfabrication required in the microfluidic device described in Chapter 2, 
making the technology more accessible to a broad range of users.  As the high-throughput 
3D culture platform becomes widely adopted by researchers across multiple fields in 
academia disciplines, medical clinics, and the pharmaceutical/biotech industries, the 
volume of meaningful data obtained by studying and screening on 3D cell models will 
increase dramatically, thus, more accurately elucidate key biological processes, predict 
clinical efficacy, and eventually expedite the drug discovery process.   
 
To further enhance the practicality of the platform, the plate must also allow for 
stable-long term culture and robust performance under high-throughput screening assays.  
These issues have been well addressed by the work described in Chapter 4.  However, 
currently the spheroid cultured as the hanging drops in the platform can only be imaged 
by taking the plate out of the humidification chamber and therefore subjecting the 
hanging drops to evaporation and compromising the serility of culture.  Future addition 
of a thin clear plate filled will water that tightly fits underneath the hanging drop plate is 
envisioned to allow automated microscopic imaging for extended period of time, which is 
a critical component in high-throughput screening applications. 
 




From the biological standpoint, conventional in vitro and in vivo models are 
limited in their ability to study the dormancy state of cancer metastasis due to technical 
difficulties associated with inducing metastatic dormancy in animals and recreating the 
complex microenvironment found in the distant metastatic sites.  3D co-culture systems 
with carefully engineered patterns will overcome thlimitations of conventional methods 
and enable the reproduction of physiologic and pathologically-relevant environment in 
vitro, which may eventually contribute to establishing better understanding of the role of 
tumor microenvironment in a variety of cancers.  Specifically, the use of 3D co-culture 
spheroids throughout this dissertation research provides the capabilities to properly 
mimic the tumor microenvironment with inherent oxygen and nutrient gradients.  Co-
culture spheroid is therefore an integral and compelling tool in studying cancer biology, 
and it especially has promising applications for CSC culture and maintenance.  The 
versatility of 3D co-culture systems will be further nhanced with the combination of 
spheroid size control and the various patterning techniques presented in Chapter 4.  The 
ability to recreate complex delicate organizations found in in vivo systems will provide a 
platform for tissue engineering and in vitro tumor models that may be immediately 





We have taken the initiatives to study tumor dormancy by establishing an in vitro 
prostate cancer micrometastases dormancy model using micro-technologies.  The 
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engineered bone metastatic niche is subsequently used to study tumor dormancy, and can 
potentially be applied to anti-cancer therapeutic development as screening and testing 
model.  Specifically, we first developed a 3D prostate cancer co-culture spheroid 
construct in a microfluidic device and characterized the growth behavior of the prostate 
cancer cells.  The recapitulation of a more physiologically-relevant prostate cancer 
growth rate in these co-culture models provided insight  into the metastatic niche.  Next, 
we developed an innovative high-throughput hanging drop platform for long-term 3D 
spheroid culture and explored a wide range of techniques to engineer micro-scale 3D 
tissues and tumors.  Such platform provided a user-friendly and practical solution to the 
obstacles hindering researchers from adopting the physiologically-relevant 3D cultures.  
Finally, to follow up on our finding of the quiescent behavior of the stem cell-enriched 
subpopulation of prostate cancer cells in the co-culture spheroids, we investigated the 
underlying biology of prostate CSC and cancer dormancy in the metastatic niche in more 
detail.  The described work represents advancements in in vitro 3D culture systems and 
models for cancer metastasis.  Despite these advances, the current metastatic prostate 
cancer model may still require further optimization n future research, which can be built 
upon the 3D culture systems and techniques developed in this dissertation research. 
 
 
6.3 Future Directions 
 
Since we have not completely validated the quiescent, dormant state of prostate 
cancer cells in the co-culture spheroids described, the current spheroid “niche” should be 
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refined and optimized for dormant prostate cancer cell culture before proceeding to actual 
anti-cancer drug screening.  Given the quiescent, non-proliferating behavior of the 
CD133+ subpopulation of PC-3 cells inside co-culture spheroids found in Chapter 2, it is 
promising to pursue the engineering of an in vitro prostate cancer dormancy niche from 
the CSC-enriched subpopulation.  The quiescent cell cyc ing state and the maintenance of 
CSC markers should be confirmed using flow cytometric analyses as described in 
Chapter 5.  When further refinements of the niche are required to induce prostate cancer 
cells into dormant states, the optimization process could be easily accomplished using the 
384 hanging drop array plate described in Chapter 3.  Multiple conditions could be tested 
simultaneously given the high-throughput capability of the platform.  Feasible factors to 
manipulate include different co-culture ratios of the cancer and support cell types, and 
different spatial localization and distribution of the different co-culture cell types within 
the spheroid constructs.  The effect of these different conditions on the prostate cancer 
cell proliferation rate should be investigated.  Patterning the location of specific co-
culture cell types within a spheroid can be achieved using techniques presented in 
Chapter 4.  Complex patterns (Figure 6.1) of the co-culture cell types are envisioned to be 
engineered by integrating a combination of concentric layer patterning with side-by-side 
Janus spheroid patterning.  Sophisticated patterning a d precise localization of the 
different niche components within co-culture spheroids would allow for exploration of 
the different roles of the endosteal versus the vascul r niche.  The ideal dormant 
metastatic niche should allow for the culture and maintenance of quiescent progenitor-
like prostate cancer cells that often escape from cnventional chemotherapeutic agents 
that target actively proliferating cells.  Various factors from the cancer and support cells 
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can also be manipulated through knockdowns of key genes implicated in cancer stem 
cells, metastasis, and dormancy.  This will provide a greater understanding of the 
underlying molecular mechanisms in regulating dormancy that could potentially lead to 
the elucidation of new cellular and molecular targets for anti-cancer therapy.  
Collectively, these research efforts will pave the way for screening of drugs against the 
established in vitro 3D dormant prostate cancer bone micrometastases on the 384 hanging 
drop plate. The high-throughput and user-friendly 3D spheroid culture platform readily 
usable by clinicians also offers the capability to test anti-cancer drugs on patient-derived 
cells for special individualized treatments. 
 
As an immediate first step to understand the prostate CSC population further, 
conventional anti-cancer drugs such as 5-fluorouracil (5-FU) that targets proliferation 
could be applied to bulk PC-3 co-culture spheroids (same model as presented in Chapter 
2, but cultured in the 384 hanging drop array plate developed in Chapters 3 and 4).  The 
PC-3 cell population would subsequently be isolated n  then analyzed for the number of 
CD133+ PC-3 progenitor cells that remain in the co-culture spheroid constructs.  The 
actively proliferating CD133- subpopulation of PC-3 cells is expected to be killed by anti-
proliferation drugs while the quiescent CD133+ subpopulation of PC-3 cells is expected 
to be resistant to the anti-proliferation drugs.  Therefore, the remaining prostate cancer 
cells to be analyzed are expected to be enriched in the CD133+ progenitor population.  
Alternatively, PC-3 cells could be sorted into CD133+ and CD133- subpopulations prior 
to the formation of the co-culture spheroid constructs.  Anti-cancer drugs would then be 
applied to both CD133+ and CD133- PC-3 co-culture spheroids, and the effect of the 
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drugs on these two subpopulations of PC-3 cells would be compared.  After drug 
treatment on the co-culture spheroids and isolating the prostate cancer cells, QPCR can 
be performed for the CD133+ subpopulation (and possibly the CD133+/CD44+ 
subpopulation) versus the entire population to explore and compare the expression levels 
of key stem cell and metastasis relevant genes.  3D co-culture of prostate cancer cells 
with osteoblasts and endothelial cells is expected to affect the gene expression levels in 
prostate cancer cells as compared to conventional 2D mono-cultures (as explored in 
Chapter 5).  This will provide greater insights into the true prostate CSC markers as well 
as the underlying mechanisms regulating the prostate CSCs.  Altogether, the development 
of the 3D prostate cancer co-culture spheroid model as well as the high-throughput 
hanging drop array plate will become essential and useful tools in studying prostate CSCs 
from a novel approach to provide ground-breaking impacts in the field. 
 
 
6.4 Concluding Thoughts 
 
The work described here does not signify that we have cured cancer.  
Nevertheless, it marks a significant step towards the development of a revolutionary class 
of anti-CSC drugs that seems promising in eradicating cancer at the dormancy stage 
before malignant cancer cells propagate and develop int  metastatic outbreak that is often 
lethal.  The prostate cancer bone metastasis niche model has brought valuable insights to 
cancer biology.  It also serves as an accurate model that bridges the gap between 
conventional artificial 2D monolayer systems and the actual in vivo environment.  The 
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384 hanging drop plate further represents a technological breakthrough that could 
potentially revolutionize the current 3D cell culture standards in biomedical disciplines 
and drug screening platforms in the pharmaceutical industry. 
 
Development of novel anti-cancer therapeutics is an interdisciplinary effort that 
requires contributions from a range of scientific and engineering fields in academia and 
industry.  Our work is only a small part of a continual and collective endeavor in 
realizing the goal of curing cancer.  Together, with huge ongoing efforts and innovations 
from around the world dedicated to finding a cure for cancer, the future will witness 
exciting medical breakthroughs and advancements in oncology.  Finding a cure for 
cancer is not a simple problem, but it will be within our reach in the near future as we 
unravel the underlying cancer progression mechanisms tep by step.  As simple but 
powerful tools, in vitro 3D culture systems and models for physiological and pathological 
tissues are envisioned to have tremendous impact on bi logical studies and drug 
discovery, and will continue to serve as the fundamental basis for more biomedical 




Figure 6.1. Schematic illustration of an engineered metastasis niche with the various 
component cells spatially patterned to model the in vivo hematopoietic stem cell (HSC) 
niche. 
 
